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II.	Abstract		Multi-drug	 resistant	 bacteria	 have	 become	 a	 real	 threat	 to	 public	 health	worldwide.	 Gram-negative	 bacteria,	 in	 particular,	 have	 shown	 high	 level	 of	antibiotic	 resistance	 due	 to	 the	 presence	 of	 an	 additional	membrane,	 known	 as	outer-membrane	 (OM),	 that	 acts	 as	 an	 extra	 barrier.	Most	 antibiotics	 enter	 the	cells	via	a	particular	class	of	outer-membrane	proteins	(OMPs)	known	as	porins.	Porins	 are	 β-barrel	 channels	 that	 allow	 the	 passive	 diffusion	 of	 hydrophobic	compounds.	The	porins	are	known	to	select	against	molecules	on	the	basis	of	size	and	 charge.	 When	 exposed	 to	 antibiotics,	 bacteria	 can	 modify	 the	 OM	permeability	 by	 altering	 their	 porins	 profile.	 Mutations	 affecting	 the	 size	 and	conductivity	 of	 the	 pore	 channel,	 and	 modification	 of	 the	 level	 of	 porins	expression	are	 just	 few	examples	of	how	the	bacteria	can	decrease	 the	 influx	of	antibiotics.			In	 order	 to	 better	 understand	 their	 interaction	 with	 antibiotics,	 this	 thesis	presents	 structural	 and	 functional	 studies	 on	 porins	 from	 pathogenic	 bacteria.	The	structure	of	the	natively	expressed	major	outer-membrane	protein	(MOMP)	from	Campylobacter	 jejuni	 was	 determined,	 reveling	 the	 presence	 of	 a	 calcium-binding	site	inside	the	channel.	Electrophysiology	and	 in	silico	modeling	analysis	have	 shown	 to	 be	 important	 for	 the	 stability	 and	 the	 function	 of	 the	 protein.	Omp50	from	C.	jejuni	was	expressed	in	E.	coli	and	its	tyrosine	kinase	activity	was	analyzed	 in	 vitro.	 Finally,	 the	 structures	 of	 the	 two	 major	 porins	 from	
Enterobacter	aerogens	were	determined	and	compared	to	their	orthologs	within	the	Enterobacteriaceae	family.	Further,	a	liposome-swelling	assay	(LSA)	was	used	
	 iv	
to	 determine	 the	 rate	 of	 permeation	 of	 clinically	 relevant	 antibiotics	 through	 a	series	 of	 porins.	 Combining	 these	 data	 allow	 a	 more	 detailed	 molecular	understanding	of	translocation.	
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1.1	Introduction	
	
1.1.1	Gram-negative	outer-membrane:	an	overview	
	Bacteria,	like	all	living	cells,	possess	an	envelope	that	allows	them	to	protect	the	cytoplasmic	 contents	 from	 the	 surrounding	 environment.	 In	 addition	 to	 this	membrane,	Gram-positive	 and	Gram-negative	 bacteria	 [1]	 have	 a	 peptidoglycan	layer.	Gram-negative	bacteria	possess	a	further	additional	‘outer’	membrane	that	has	 a	 distinctive	 composition.	 This	 introduction	 will	 focus	 on	 the	 membrane	structure	 and	 composition	 of	 the	 Gram-negative	 bacteria,	 with	 a	 particular	interest	in	the	outer-membrane.			Gram-negative	bacteria	are	composed	of	two	chemically	distinct	membranes,	the	inner	 membrane	 (IM)	 (separates	 cytoplasm	 from	 periplasm),	 and	 the	 outer-membrane	(OM)	(separates	periplasm	from	extra-cellular	space).	The	periplasm,	is	an	aqueous	compartment	containing	a	 layer	of	peptidoglycan.	While	 the	IM	is	composed	 of	 a	 bilayer	 of	 phospholipids	 (with	 ethanolamine	 and	 phosphatidyl	glycerol	 being	 the	most	 abundant	 phospholipids),	 the	 composition	 of	 the	OM	 is	more	complex.	The	inner	leaflet	of	the	OM	(facing	the	periplasm)	shows	a	similar	composition	 to	 the	 IM,	 whereas	 the	 outer	 leaflet	 is	 mainly	 composed	 of	glycolipids,	which	form	the	lipopolysaccharide	(LPS)	[2].		The	LPS	is	essential	for	the	Gram-negative	survival	and	is	therefore	ubiquitously	produced	in	all	species.	The	structure	of	the	LPS	has	been	extensively	studied	in	the	last	few	decades,	and	it	has	now	been	well	characterized.	The	LPS	is	organized	
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in	three	main	regions	(from	the	outer	leaflet	to	the	extra-cellular	space):	Lipid	A,	the	core	and	the	O-chain	(Figure	1.1)	[3].	Lipid	A	is	the	most	hydrophobic	part	of	the	 LPS	 and	 it	 is	 mainly	 formed	 by	 β-D-GlcN-(1-6)-α-D-GlcN	 disaccharide	 with	two	 phosphoryl	 groups	 attached	 [4]	 and	 it	 is	 this	 molecule	 that	 functions	 as	endotoxin.	Endotoxin	is	responsible	for	the	activation	of	an	immune	response	in	mammals,	which,	 in	 severe	 cases	 can	 lead	 to	 septic	 shock	 and	 eventually	 death	[5].	The	core	is	composed	of	repeating	units	of	sugar.	The	section	of	the	core	close	to	 the	 Lipid	 A,	 also	 known	 as	 inner	 core,	 is	 primarily	 composed	 of	 3-deoxy-D-manno-octulosonic	 acid	 (Kdo)	 and	L-glycero-D-manno	heptose	 (Hep),	while	 the	outer	core,	in	proximity	to	the	O-chain,	is	composed	of	hexoses	and	hexosamine.	Finally,	the	O-chain	is	the	most	exposed	and	the	most	variable	part	of	the	LPS	[6].	It	 is	 comprised	 of	 repeating	 units	 of	 polysaccharides,	 of	 which	 the	 lengths	 and	composition	 vary	 from	 species	 to	 species.	 Some	mutants	 do	 not	 express	 the	O-antigen	and,	in	this	case	the	LPS	is	termed	rough	[7].										
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Figure	 1.1:	 LPS	 schematic	 representation.	 The	 three	main	 regions	 forming	 the	 LPS	(Lipid	A,	Core	and	O-antigen)	are	highlighted	 in	 the	 figure.	The	O16	E.	coli	O	antigen	 is	used	 as	 an	 example.	 The	 lipid	 A	 is	 structurally	 composed	 of	 a	 β-(1-6)-linked	 D-GlcN	disaccharide,	 to	which	 are	 attached	 up	 to	 four	 (per	monosaccharide)	 acyl	 acids	 chains	(e.g.	palmitic	and	myristic	fatty	acids)	.	The	lipid	A	is	directly	connected	to	the	inner	core	through	a	α2-6	bond	between,	the	Kdo	and	the	glucosamine.		The	outer	core	is	composed	of	several	1-3	β	bound	hexoses	(D-glucose,	D-mannose,	D-galactose),	with	the	last	hexose	directly	bound	to	the	O-antigen.	The	O-antigen	is	a	glycan	polymer	in	the	outermost	part	of	the	LPS.	Figure	adapted	from	[8].		
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1.1.2	Outer-membrane	proteins	
	The	outer-membrane	 is	embedded	with	proteins	 that	display	a	characteristic	β-barrel	 arrangement.	 To	 date,	 many	 outer-membrane	 protein	 (OMP)	 structures	have	been	solved	by	X-ray	crystallography	and	almost	all	of	these	share	common	features	 that	 can	 be	 summarized	 as	 follows:	 i)	 they	 are	made	 of	 antiparallel	 β-strands	connected	to	each	other	(the	number	of	the	β-strands	differs	amongst	the	OMPs,	 ranging	 from	 a	minimum	 of	 8	 to	 a	maximum	 of	 26),	 (Wza	was	 the	 first	exception	to	this	rule	[9])	ii)	both	the	N-	and	the	C-terminus	face	the	periplasmic	space,	iii)	the	β-strands	are	connected	by	longs	loops	(L)	facing	the	extra-cellular	space	and	short	turns	(T)	facing	the	periplasmic	space,	iv)	the	loops	represent	the	most	variable	part	of	the	barrel,	vi)	in	most	(but	not	in	all)	the	OMPs	the	L3	folds	back	 inside	 the	 channel	 to	 form	 the	 so-called	 constriction	 zone	 or	 eyelet,	 vii)	when	 trimerized,	 a	 non-polar	 core	 is	 formed	 along	 the	 threefold	 axis,	 viii)	 the	external	surface	of	 the	barrel	 (embedded	 in	 the	 lipid	bilayer)	consists	mainly	of	hydrophobic,	uncharged	amino-acids[10],[11].		The	OMPs	play	multiple	roles	that	are	essential	for	the	viability	of	bacteria,	they	form	 channels	 for	 the	 uptake	 of	 nutrients,	maintain	 the	 bilayer	 asymmetry,	 are	involved	in	cellular	adhesion,	and	can	also	act	as	enzyme	(e.g.	protease)	[12],[13].		
1.1.3	Passive	transport	through	the	OM:	Porins	
	Porin	 transporters	exemplified	by	OmpC	are	water	 filled	 channels	embedded	 in	the	OM,	 allowing	 the	passive	diffusion	 of	 polar	molecules	 [14].	 Like	most	 other	
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OMP,	porins	show	a	β-barrel	structure	with	several	long	external	loops	and	short	periplasmic	 turns	 (Figure	 1.2).	 Porins	 can	 adopt	 either	 a	 monomeric	 or	(homo)trimeric	 conformation	 [15],[16].	 The	 latter	 is	 stabilized	 due	 to	 the	interaction	 within	 the	 L2	 of	 one	 monomer	 and	 the	 β-strands	 of	 the	 neighbor	monomer.	In	vitro,	this	interaction	can	be	disturbed	using	chaotropic	agents	or	by	heat,	 leading	 to	 the	partial	 or	 complete	dissociation	of	 the	 trimer	 [17].	 β-barrel	proteins	benefit	 from	a	high	 level	of	 stability	due	 to	numerous	hydrogen	bonds	formed	 among	 the	 β-sheets	 [18].	 Several	 studies,	 however,	 have	 identified	“weakly	 stable”	 regions	 within	 the	 transmembrane	 domain	 of	 trimeric	 porins	[19],[20],[21].	 Interestingly,	 those	 regions	 are	 stabilized	 by	 the	 formation	 of	protein-protein	 interfaces	(oligomerization).	 In	OmpF,	a	trimeric	porin	of	E.	coli,	the	amino	acids	R100,	G19,	G135,	and	N141	have	been	identified	as	weakly	stable	residues	 [21].	Site-directed	mutagenesis	of	 these	residues	 leads	 to	both	a	stable	dimer	and	monomer	of	OmpF	[21].			L3	plays	 an	 important	 role	 in	 the	diffusion	of	molecules	 through	 the	pore.	 This	loop	 folds	back	halfway	 through	 the	channel,	narrowing	 its	diameter.	 Inside	 the	barrel,	 negatively	 charged	 amino	 acids,	 lying	 in	 the	 L3,	 interact	with	 positively	charged	amino	acids	(either	Lys	or	Arg)	located	opposite	the	Loop	[22],[23].	The	distribution	of	 the	 charges	 creates	an	 internal	 electric	 field,	which	 compensates	for	desolvation	and	permits	the	translocation	of	polar	molecules	[24].	The	outside	of	the	barrel,	unlike	the	inside,	is	predominantly	uncharged	and	hydrophobic,	as	it	would	be	expected	for	proteins	inserted	in	a	lipidic	membrane.			
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Figure	1.2:	Cartoon	representation	of	OmpC	from	E.	coli.	(A)	Extracellular	view	of	OmpC	trimer	(B)	Side	view	of	OmpC	monomer.	Extracellular	loops	are	indicated	with	L	and	periplasmic	turns	with	T.	(PDB	code:	2J1n)		Non-specific	(also	known	as	general)	and	specific	porins	are	differentiated	based	on	 the	 level	 of	 specificity	 shown	 for	 their	 substrates.	 Normally	 16-β-stranded,	general	 porins	 allow	 permeation	 of	 substances	 with	 a	 MW	 lower	 than	 600	 Da	with	a	slight	selectivity	for	cations.	Cation-selectivity	in	general	porins	–	such	as	in	 OmpC	 [25]	 and	 OmpF	 [26]	 from	 E.	 coli,	 and	 in	OmpK36	 and	 OmpK35	 from	
Keisbiella	 pneumonia	 [27]	 –	 has	 been	 largely	 demonstrated	 by	 single	 channel	experiments.	 Selectivity	 is	 caused	 by	 an	 excess	 of	 negatively	 charged	 residues	located	 inside	 the	 channel	 [28],[29],[30],[27].	 The	 majority	 of	 Gram-negative	bacteria	 possess	 at	 least	 one	 general	 porin,	 typically	 expressed	 in	 high	 copies	number	 [31].	 For	 instance,	 it	 has	 been	 estimated	 that	 OmpF	 from	 E.	 coli	 is	normally	present	at	105	copies	per	cells	[31].	
L1	
L2	
L3	
L4	
L5	 L6	
L7	
L8	
T1	
T2	
T3	
T4	 T5	 T6	
T7	
T8	
A.	 B.	
Chapter	1:	Structure	and	function	of	outer-membrane	proteins	
	 9	
The	maltoporin	LamB	from	E.	coli	[32]	and	the	sucrose-specific	porin	SrcY	 from	
Salmonella	 typhimurium	 [33],[34]	 are	 well-characterized	 examples	 of	 specific	(sugar)	 porins.	 A	 common	 feature	 of	 sugar	 transporting	 porins	 is	 an	 array	 of	aromatic	 amino	 acids	 which	 run	 in	 lanes	 inside	 the	 inner	 wall	 of	 the	 channel,	commonly	 known	 as	 “greasy	 slide”	 (Figure	 1.3)	 [35].	 Site-directed	mutagenesis	studies	 have	 shown	 the	 importance	 of	 the	 greasy	 slide	 on	 sugar	 translocation	[36].	 The	 aromatic	 residues	 help	 lining	 the	 sugars	 inside	 the	 channel	 by	interacting	 with	 their	 hydroxide	 groups,	 lowering	 the	 energy	 barrier	 for	permeation	 [37],[38].	 Specific	 porins	 are	 expressed	 in	 low	 copy	 numbers	 and	their	expression	depends	upon	certain	limiting	growth	conditions.			
		
Figure	1.3:	Greasy	slide	in	LamB	from	E.	coli.	LamB	monomer	is	colored	in	green.	The	amino	acids	forming	the	greasy	slide	are	shown	in	sticks	and	colored	in	magenta	(PDB	code:	1MAL).	
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Pseudomonas	aeruginosa	 possess	another	 class	of	 substrate-specific	porins.	This	is	called	the	“Outer	membrane	Carboxylic	acid	Channel”	(Occ)[39].	 Interestingly,	no	general	porins	have	been	identified	in	P.	aeruginosa,	perhaps	correlating	with	this	pathogens	inherent	resistance	to	permeation	of	antibiotics	[40],[41].	The	Occ	porins	 can	 be	 divided	 in	 two	 sub	 families	 OccD	 (specific	 for	 amino	 acids)	 and	OccK	(specific	for	cyclic	negatively	charged	molecules)	[42],[43].	In	the	Occ	porins	the	substrates	are	guided	through	the	pore	due	to	a	so-called	“basic	ladder”.	This	is	 a	 string	 of	 basic	 amino	 acids	 (Lys	 and	Arg)	 that	 interact	with	 the	 substrate’s	carboxyl	group	[44]	(Figure	1.4).	To	date,	several	structures	of	the	Occ	members	have	 been	 solved,	 showing	 that	 although	 trimeric	 in	 solution,	 these	 porins	crystallize	as	monomers	of	18-β-strands	[45].			
	
Figure	1.4:	Basic	ladder	in	OccD1	from	Pseudomonas	aeruginosa.	OccD1	monomer	is	colored	in	green.	Amino	acids	forming	the	so-called	“basic	ladder”	are	shown	in	sticks	and	colored	in	orange	(PDB	code:	4FOZ).		
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In	the	last	decade,	an	increased	number	of	porin	structures	have	become	available	[10],	 uncovering	 the	 presence	 of	 porins	 with	 unusual	 characteristics	 [46].	 For	example,	 recently,	 the	 x-ray	 structure	of	 the	 cyclodextrin	metabolism	A	 (CymA)	porin	from	Klebsiella	oxytoca	has	uncovered	a	diverse	organization	of	the	internal	loops	and	thus	a	peculiar	mechanism	of	uptake	[47],[48].	CymA	is	a	14-β-sheets	cyclodextrine-specific	channel	with	shorts	extracellular	loops.	Interestingly,	none	of	them	fold	back	to	constrict	the	pore	[48]	(Figure	1.5	A-B).	In	CymA,	in	fact,	the	pore	is	kept	closed	due	to	an	N-terminus	inner	plug	that	interacts	with	the	wall	of	the	 channel.	 Such	 interaction	 is	 disturbed	 when	 the	 cyclodextrines	 approach,	leading	to	the	opening	of	the	channel	and	subsequent	translocation	[48].			Another	particularly	unusual	14-β-strand	porin	is	OmpG	from	E.	coli	K-12.	Unlike	any	other	porins	described	so	far,	OmpG	channel	is	entirely	open,	due	to	the	lack	of	the	L3,	or	any	inner	plugs	(Figure	1.5	C-D)	[16].	The	large	diameter	of	the	pore	could	allow	the	entry	of	highly	toxic	compounds	that	would	compromise	the	OM	permeability	and	hence,	the	bacterial	viability.	It	is,	probably	for	this	reason	that,	OmpG	 is	 not	 constitutively	 expressed	 but	 expression	 occurs	 under	 specific	conditions	[16].		
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Figure	1.5:	Cartoon	representation	of	14-β-stranded	porins.	(A)	Side	view	of	CymA.	The	barrel	 is	 colored	 in	 green	and	 the	 inner	plug	 in	magenta.	 (B)	Extracellular	 view	of	CymA.	 The	 substrate,	 cyclodextrine,	 is	 bound	 to	 the	 binding	 site.	 The	 molecule	 of	cyclodestrine	is	displayed	in	stick	and	colored	in	magenta.	(C)	Side	and	(D)	extracellular	view	of	OmpG	from	E.	coli	(PDB	code:	4D5B	and	2F1C,	respectively).			
A.	 B.	
C.	 D.	
Inner	plug	
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1.1.4	Active	transport	through	OM:	TonB-dependent	transporters		TonB-dependent	 transporters	 (TBDTs)	 are	 a	 class	 of	 OMPs	 which	 allow	 active	translocation	of	essential	substances	such	as	iron	(chelates	to	specific	molecules	called	 siderophore),	 cobalt	 and	 nickel.	 It	 also	 allows	 the	 translocation	 of	substances	 such	 as	 vitamin	 B12	 and	 carbohydrates	 [49].	 To	 date,	 several	structures	 of	 TBDTs	 have	 been	 reported,	 including	 FhuA	 [50],	 FepA	 [51],	 PiuA,	PirA	 [52]	 and	 BtuB	 [53].	 Those	 structures	 revealed	 that	 the	 TBTDs	 are	 22-β	stranded	barrel	with	an	inner	“plug	domain”,	folded	back	inside	the	barrel	(Figure	1.6).			
	
Figure	1.6:	FhuA,	TonB	dependent	transporter	of	E.	coli.	(A)	FhuA	in	complex	to	TonB	C-terminus.	FhuA	 is	colored	 in	yellow,	 the	 inner	plug	 in	magenta	and	TonB	 in	blue.	 (B)	Shows	the	inner	plug.	Some	β-sheets	were	removed	to	improve	the	view	of	the	plug	(PDB	code:	2GRX).	
A.	 B.	
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As	no	source	of	energy	is	available	at	the	level	the	OM,	active	translocation	occurs	by	 transducing	 the	proton	motive	 force	 (pmf)	 generated	 in	 the	 IM	by	 a	protein	complex,	 namely	 TonB-ExbB-ExbD	 [49][54][55].	 Specifically,	 as	 a	 result	 of	 the	binding	of	the	ligand,	the	TBDTs	undertake	conformational	changes	that	lead	the	N-terminal	 of	 the	 plug	 domain,	 also	 known	 as	 TonB	 box,	 to	 reach	 and	 interact	with	 the	C-terminal	domain	of	 the	TonB	protein,	 at	 the	 level	 of	 the	periplasmic	space.	 Such	 interaction	 is	 necessary	 to	 transfer	 the	 energy	 for	 the	 ligand	translocation	 (Figure	1.7)	 [56],[57].	Although	 the	 crystal	 structure	of	 the	TonB-ExbB-ExbD	 complex	 has	 been	 recently	 determined	 [58],[59],	 the	 transport	mechanism	has	yet	to	be	understood.			
	 	
Figure	1.7:	Schematic	representation	of	TBDT	mediated	transport.	Transport	of	the	siderophore-Fe3+occurs	via	specific	TBTD	receptor	(green,	PDB	code:	2GRX).	Upon	ligand	interaction	 the	 receptor	 interacts	 with	 the	 C-terminus	 of	 TonB	 (magenta,	 PDB	 code:	2GRX)	giving	the	power	stroke	for	translocation.	The	ExbB/ExbD	complex	is	depicted	in	blue	(ExbB)	and	pink	(ExbD)	(PDB	code	5SV1).	Picture	adapted	from	[59].	
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Recently	 the	 x-ray	 structure	 of	 the	 starch	 utilization	 system	 (SusCD)	 became	available,	 reveling	 a	 diverse	 example	 of	 TBDT	 [60].	 In	 fact,	 the	 SusCD	 complex	from	Bacteroides	thetaiotaomicron	solved	by	Glenwright	et	al.,	disclosed	a	novel	substrate-binding	mechanism	[60].	SusD	is	a	lipoprotein	that	acts	as	a	lid	on	the	top	of	SusC,	a	typical	22-β	stranded	TBTDs	(Figure	1.8).	In	absence	of	the	ligand,	SusD	is	in	an	open	and	motile	state	to	then	switch	to	a	closed	conformation	upon	ligand	binding.	The	 ligand	 is	 located	 in	between	 the	 interface	of	 SusC	and	SusD	[60].	As	for	the	case	of	the	canonical	TBDTs,	the	plug	domain	is	pushed	away	from	the	 barrel	 to	 interact	 with	 the	 TonB-ExbB-ExbD	 complex	 and	 complete	 the	translocation.			
	
Figure	 1.8:	 SusCD	 complex	 from	 Bacteroides	 thetaiotaomicron.	 SusC,	 TonB	dependent	transporter,	 in	complex	with	the	lipoprotein	SusD.	SusC	is	colored	in	yellow,	the	inner	plug	in	magenta	and	SusD	in	blue	(PDB	code:	5FQ6).	
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1.1.5	OMPs	with	enzymatic	activity	
	To	date,	only	few	outer-membrane	proteins	have	been	characterized	as	enzymes	[61],[62].	Those	OMPs	have	adapted	to	modify	the	outer-membrane	structure	as	a	response	 to	external	 stimuli	and	 threats	 [61].	For	 instance,	OmpT	porin	 from	E.	
coli,	 a	 well-characterized	 member	 of	 the	 omptine	 family,	 is	 involved	 in	 the	catalysis	of	antimicrobial	peptide	[63].	The	x-ray	structure	of	OmpT	showed	a	10	β-sheets	barrel	with	the	catalytic	residues	(D83,	D85,	D210,	H212)	placed	at	the	level	of	the	extracellular	loops	(Figure	1.9	A)	[64].	The	structural	organization	of	the	catalytic	pocket	 is	stabilized	due	 to	 the	 interaction	with	 the	LPS,	so	 that	 the	LPS	 is	 considered	 as	 a	 cofactor	 of	 OmpT	 [65].	 In	 silico	 modeling	 analysis	 have	suggested	 that	 a	molecules	 of	 water,	 located	 in	 between	 the	 residues	 D83	 and	H212,	 it	 is	 directly	 involved	 in	 the	 hydrolysis	 of	 the	 peptide	 bound	 of	 two	consecutives	basic	amino	acids	[66].		
	PagP	and	PagL	from	E.	coli	are	another	example	of	enzymatic	OMPs.	Both	porins	are	monomeric	and	8-β-stranded	and	are	involved	in	the	modification	of	the	LPS	[67],[68].	 Specifically,	 PagP	 and	 PagL	 undertake	 the	 palmitoylation	 and	 the	deacylation	 of	 the	 Lipid	 A,	 respectively[69],[70].	 Such	 modification	 have	 been	linked	 to	 an	 increase	 (palmytoylation)	 and	 a	 decrease	 (deacylation)	 of	 LipidA	endotoxicity	[71].				OMPLA,	 a	 monomeric	 12-β-stranded	 porin,	 is	 also	 involved	 in	 the	 LPS	modification.	 OMPLA	 is	 a	 calcium-dependent	 phospholipase	 able	 to	 hydrolyze	
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glycerophospholipids	 in	 the	 outer	 leaflet	 of	 the	 outer-membrane	 [72].	Interestingly	 the	monomeric	 form	 of	 this	 protein	 is	 inactive	 [73].	 Activation	 of	OMPLA	 occurs	 via	 dimerization	 and	 it	 is	 triggered	 by	 alteration	 of	 the	 LPS	asymmetry	[73],[74]	(Figure	1.9	B).		Further,	 LpxR	 and	 LpxQ	 have	 too	 been	 identified	 as	 OMP	 enzymes.	 They	 are	involved	 in	 the	 acyloxyacylation	 and	 oxidation	 of	 the	 Lipid	 A,	 respectively	[75],[76].	No	structural	information	is	yet	available	for	either	of	those	enzymes.			 	
	
Figure	 1.9:	 OMPs	 enzymes.	 (A)	 Crystal	 structure	 of	 OmpT	 is	 colored	 in	 yellow	 (PDB	code:	 1I78).	 The	 amino	 acids	 proposed	 as	 catalytic	 domain	 are	 shown	 in	 sticks	 and	colored	 in	 blue.	 (B)	 Dimer	 of	 OMPLA	 (colored	 in	 pea-green)	 (PDB	 code:	 1QD6).	 The	calcium	molecules	are	depicted	as	spheres	and	colored	in	purple.					
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1.1.6	Biosynthesis	of	OMPs		The	biosynthesis	of	OMPs	starts,	like	any	other	protein,	in	the	cytoplasm.	Several	proteins,	 often	 associated	 to	 form	multi-protein	 complexes,	 are	 involved	 in	 the	OMPs	 assembly	 [77],[78].	 Chaperones,	 both	 in	 the	 cytoplasm	 and	 in	 the	periplasm,	keep	 the	precursors	of	 the	OMPs	 (pre-OMPs)	unfolded	 [79],[80],	 the	SEC	complex	allows	the	pre-OMPs	to	pass	through	the	IM	and	finally	the	β-	barrel	assembly	machinery,	 also	 known	 as	 BAM,	 fold	 and	 insert	 the	 OMPs	 in	 the	 OM	(Figure	1.10)[81].			
		
Figure	 1.10:	 Cartoon	 representation	 of	 the	 OMPs	 assembly.	 The	 pre-OMPs	 are	targeted	to	the	IM	via	the	SecAB	complex,	and	reached	the	periplasm	through	the	secYEG	translocone.	 Here	 several	 chaperons	 bind	 the	 pre-OMPS	 and	 deliver	 them	 to	 the	 BAM	complex.	Figure	adapted	from	[81]		
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The	 majority	 of	 OMPs	 contains	 a	 signal	 peptide	 that	 allows	 the	 bacteria	 to	recognize	and	target	the	protein	to	the	correct	translocon.	The	signal	peptide	is	a	three-part	sequence,	 located	at	N-terminus	of	the	pre-OMPs	and	it	 is	usually	18-20	amino	acids	long	[82].	The	three	motifs	that	comprised	the	signal	peptide	are	identified	as	n-region	(at	the	N-terminus	of	the	sequence),	h-region	(composed	of	hydrophobic	 amino	 acids)	 and	 c-region	 (at	 C-terminus	 of	 the	 sequence,	 often	contains	an	A-A	consensus)[83].			A	two	proteins	complex,	SecAB,	is	responsible	to	deliver	the	pre-OMPs	to	the	SEC	translocon	[84].	SecA	is	an	ATP-powered	protein,	whose	role	is	to	carry	the	pre-OMPs	to	the	translocon,	while	the	chaperon	SecB	which	bounds	the	pre-OMPs	in	specific	 sequences,	 usually	 masked	 in	 the	 folded	 protein,	 keeps	 them	 unfolded	[85].		Although	 the	 majority	 of	 the	 proteins	 cross	 the	 IM	 maintaining	 an	 unfolded	conformation,	fully	folded	proteins	can	also	translocate	through	the	IM,	by	using	an	 alternative	 translocon,	 known	 as	 twin-arginine-translocase	 (TAT)	 [86].	 In	E.	
coli	 the	TAT	 system	consists	of	 three	 inner	membrane	proteins,	TatA,	TatB	and	TatC.		The	signal	peptide,	that	target	the	proteins	to	the	TAT	complex	includes	the	consensus	 sequence	 Ser/Thr-Arg-Arg-(X)-Phe-Leu-Lys	 (with	 X	 being	 any	 polar	amino	acid)[86].	When	the	proteins	reach	the	TAT	complex,	a	H+	proton	gradient	drives	the	proteins	through	the	translocon	to	the	periplasm	[87].			
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The	SecYEG	translocon	is	a	multi-protein	complex	composed	of	the	three	proteins	SecY,	 SecE	 and	 SecG	 [88].	 A	 homologue	 of	 the	 bacteria	 SEC	 translocon,	 the	translocon	 Sec61αβγ,	 has	 been	 identified	 in	 Eukaryotes	 [89].	 Although	 the	mechanism	 of	 translocation	 through	 the	 SEC	 complex	 has	 not	 been	 fully	understood,	 it	 is	clear	that	SecA	plays	a	major	role	[90].	During	translocation,	 in	fact,	SecA	partially	 insert	 itself	 through	the	translocon	pore	and	through	several	cycle	 of	 binding	 and	 hydrolysis	 of	 ATP	 gives	 the	 energy	 necessary	 for	 the	 pre-OMPs	to	translocate	[91][90].			In	 the	 SEC	 pathway,	 once	 the	 protein	 has	 crossed	 the	 IM,	 a	 signal	 peptidase	cleaves	the	signal	peptide	and	releases	 the	pre-OMPs	 in	 the	periplasm.	The	pre-OMPs	 are	 recognizes	 by	 different	 chaperons	 (SurA,	 Skp,	 FkpA	 and	 Spy)	 whose	role	 is	 to	 keep	 the	 pre-OMPs	 unfolded,	 avoiding	 their	 aggregation	 [92][93].	 In	case	 of	misfolded	proteins,	 a	 particular	 chaperone	with	 protease	 activity,	DegP,	binds	and	hence	degrades	 the	pre-OMPs	[94].	Once	the	chaperons	bind	the	pre-OMPs,	they	are	delivered	to	the	BAM	complex.		In	E.	coli	 the	BAM	machinery	 is	a	multi-protein	complex	composed	of	BamA,	an	outer-membrane	 protein,	 and	 four	 lipoproteins,	 BamBCDE,	 linked	 to	 the	 inner	leaflet	 by	 a	N-terminus	modification	 [95],	 [96].	 BamA	 is	 a	 16-β-stranded	 barrel	with	an	extended	periplasmic	domain	comprising	of	 five	repetitions	of	a	POTRA	(polypeptide-translocation-associated)	 domain	 (Figure	 1.11)	 [97],[98].	 The	POTRAs	present	a	β-α-α-β-β	architecture	and	although	structurally	identical	they	share	 low	 sequence	 identity.	 The	 POTRAs	 domain	 mediates	 BamA	 and	 BamB	
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interaction.	Deletion	of	 the	 last	 three	POTRAs	(P3-5)	 is	 lethal	 for	E.	coli,	but	not	for	 Neisseria	 gonorrhea	 [99],	 which	 implies	 that	 the	 importance	 of	 the	 single	POTRAs	on	the	bacterial	viability	is	species-specific.		
		
Figure	1.11:	Crystal	structures	of	BamA	and	BamB.	(A)	BamA	structure	is	colored	in	yellow	 and	 POTRAs	 domains	 in	 blue.	 (B)	 The	 lipoprotein	 BamB	 in	 complex	with	 P3-5	POTRAs	domains	of	BamA	(PDB	codes:	4K3B	and4XGA,	respectively).			BamA	interacts	to	BamC	and	BamE	through	BamD.	While	deletion	of	BamB,	BamC	and	BamE	 is	 tolerable,	 deletion	 of	 BamA	 and	BamD	 severely	 impairs	 the	OMPs	assembly	 leading	 to	 the	 bacteria	 death.	 BamA	 and	 BamD	 the	 only	 essential	components	of	the	BAM	system	[96].	
A.	 B.	
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	Although	the	BAM	complex	has	been	structurally	characterized,	its	mechanism	of	action	has	yet	to	be	fully	understood.	Several	in	vitro	studies,	have	demonstrated	that	most	 of	 the	OMPs	 can	 spontaneously	 (but	 slowly)	 fold	 and	 insert	 themself	into	an	artificial	lipid	bilayer	[100]	[101].	These	results	have	brought	to	the	idea	that,	in	vivo,	the	BAM	complex	might	increase	the	kinetic	of	the	OMPs	insertion	in	the	 OM,	 making	 the	 process	 more	 favorable	 [81].	 A	 BAM-assisted	 model	 has	therefore	been	proposed	to	explain	the	OMPs	assembly.	According	to	this	model,	the	BAM	complex	plays	a	dual	role:	(1)	to	direct	the	OMPs	to	the	OM	and	(2)	to	destabilize	 the	 OM	 and	 consequently	 facilitate	 the	 OMP	 insertion	 [102].	Nevertheless,	 another	 model,	 known	 as	 “BAM	 budding	 model”,	 has	 also	 been	introduced	 to	 explain	 the	 BamA-mediated	 insertion	 [103].	 According	 to	 such	model,	the	unfolded	OMP	would	use	the	first	β	strand	(β1)	of	BamA	as	a	template	to	start	 the	 folding	process.	The	growing	OMP	would	therefore	 insert	 inside	 the	BamA	 β-barrel,	 forming	 a	 BamA-preOMP	 intermediate	 complex.	 Eventually	 a	lateral	opening	of	BamA	would	lead	the	fully	folded	OMP	to	“bud”	and	insert	into	the	 outer-membrane	 [104].	 Although	 more	 studies	 need	 to	 be	 conducted	 to	elucidate	 this	 convoluted	mechanism,	 it	 is	 likely	 that	 both	mechanisms	 play	 an	important	role	in	the	OMPs	biogenesis	and	insertion	[105].					
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	1.1.7	Antibiotic	resistance:	role	of	the	OM	and	OMPs	
	Antibiotic	resistance	has	now	become	a	real	concern	for	public	health.	Particular	alarming	is	the	increasing	pace	at	which	resistance	pathogens	are	emerging,	while	the	Pharma	industries	are	struggling	to	find	new	classes	of	antibiotics	[106].		Gram-negative	bacteria	show	“intrinsic”	resistance	due	to	the	presence	of	the	OM	that	act	as	barrier	against	external	agents.	However,	hydrophobic	antibiotics,	such	as	aminoglycoside	and	chloramphenicol	can	penetrate	the	bacterial	cell	by	slowly	diffuse	through	the	OM	[107].	As	a	resistance	mechanism,	bacteria	can	modify	the	OM	 composition	 and	 hence	 alter	 its	 permeability.	 For	 instance,	 the	 pathogenic	bacteria,	 Salmonella	 enterica	 [108],	 has	 showed	 the	 ability	 to	 adjust	 the	composition	of	the	LPS,	following	the	host	colonization.	This	mechanism	is	due	to	the	presence	of	a	two	components	regulatory	system	PmrB-PmrA,	that	regulates	the	expression	of	genes	involved	in	the	modification	of	the	LPS	[109],[110].	Such	modifications	 include	 the	 incorporation	 of	 aminoarabinose	 and	phosphoethanolamine	 to	 the	Lipid	A,	which	decrease	 the	negative	charge	of	 the	LPS.	PmrBA	system	is	activated	by	the	presence	of	antibiotics	polypeptides,	such	as	 Polymixins	 B	 or	 colistins,	 and	 cationic	 antimicrobial	 peptides	(CAMPs)[110],[111].	 Those	 antibiotics	 bind	 to	 the	 anionic	 surface	 of	 the	 outer-membrane	 and	 hence	 gain	 access	 to	 the	 bacterial	 cells.	 In	 polimixins-resistant	strains	 a	 mutation	 in	 the	 PmrA	 gene	 lead	 to	 the	 expression	 of	 a	 constitutively	active	 PmrA	 and	 therefore	 to	 an	 high	 level	 of	 amminoarabinose	 and	phosphoethanolamine	 in	 the	 Lipid	 A,	 impairing	 the	 binding	 of	 polimixins	[111],[112].			
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The	number	and	the	types	of	channels	also	determine	the	level	of	permeability	of	the	OM,	 and	 therefore	 they	 play	 an	 important	 role	 in	 antibiotic	 resistance.	 It	 is	well	 established	 that	 antibiotics,	 such	 as	 β-lactams,	 cefalosphorins	 and	fluoroquinolones	 can	 cross	 the	 OM	 via	 general	 (non-specific)	 porins	 [113].	 In	pathogens,	 such	 as	P.	aeruginosa,	 the	 absence	 of	 general	 channels	 is	 associated	with	low	susceptibility	to	antibiotics	[40].			Mutations	affecting	 the	size	and	conductivity	of	 the	channel,	modification	of	 the	level	 of	 porins	 expression,	 alongside	 with	 the	 complete	 loss	 of	 one	 or	 more	general	 porins,	 are	 examples	 of	 how	 the	 bacteria	 are	 able	 to	 modify	 the	 OM	permeability	 when	 exposed	 to	 antimicrobials	 agents	 (acquired	 resistance)	(Figure	1.12)	[114],[115].		Mutation	 of	 genes	 encoding	 for	 porins	 can	 lead	 to	 an	 altered	 porin	 expression,	hence	 impaired	 antibiotic	 uptake.	 In	 P.	 auroginosa	 point	 mutation	 and/or	insertion	element	within	the	gene	encoding	for	OprD	have	been	shown	to	cause	an	 early	 termination	of	 the	 translation	process	 and	 therefore	 a	 total	 loss	 of	 the	porin.	 Clinic	 isolates	 carrying	 such	 mutation	 exhibit	 high	 level	 of	 resistance	 to	carbapenems.	 Likewise,	 in	 E.	 Cloacae,	 mutation	 of	 the	 promoter	 regulating	 the	expression	of	Ompk35	 leads	 to	a	significantly	reduction	of	 the	expression	 levels	(up	to	20-fold	less	expressed),	causing	a	decreased	ertapenem	susceptibility.		Antibiotics	resistance	can	also	be	linked	to	mutations	within	genes	involved	in	the	regulation	 of	 porins,	 as	well	 as	 efflux	 pumps,	 expression	 [116].	MarA,	SoxS	and	
Rob	are	transcriptional	regulators	highly	conserved	in	the	Gram-negative	bacteria	
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[117],[118],[119].	Those	genes	are	activated	by	several	external	stimuli,	such	us	oxidative	 stress,	 pH	 changes	 and	 antibiotics	 [120].	 Once	 activated,	 they	 up-regulate	the	expressions	of	efflux	pumps,	such	as	TolC-AcrAB	and	small	RNAs	like	
micF	and	down-regulate	the	expression	of	porins	such	as	OmpF	[121],[122][123].	Point	 mutation,	 insertion	 element	 and	 deletion	 of	 those	 genes	 lead	 to	 a	 MDR	phenotype	 and	 to	 an	 increased	 minimum	 inhibitory	 concentration	 (MIC)	 for	different	classes	of	antibiotics[116],	[124],.		
	
Figure	 1.12:	 Schematic	 representation	 of	 porins	 regulation	 under	 antibiotics	
pressure.	Antibiotics	exposure	leads	the	bacteria	to	alter	the	permeability	of	the	OM,	by	modifying	the	expression	level	of	its	porins.	Picture	adapted	from	[115].				
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Mutation	 of	 amino	 acids	 located	 in	 the	 loop	 3	 has	 also	 been	 associated	 to	 a	decreasing	antibiotic	susceptibility	[125].	G119D	mutation	in	OmpF	and	similarly	G112D	mutation	 in	Omp36	 from	Enterobacter	aerogene	and	D116A	mutation	 in	OmpU	from	Vibro	cholera	have	been	found	in	clinic	isolates	resistant	to	β-lactams	and	 cefalosphorins	 [22],	 [126].	 In	 most	 organisms,	 different	 mechanisms	synergistically	function	to	protect	the	bacterial	cell	from	the	effect	of	antibiotics.	In	 this	phenomenon,	known	as	MIC	creep,	alongside	an	altered	OM	the	bacteria	would	 increase	 the	 expression	 of	 efflux	 pumps	 (thus	 decrease	 the	 amount	 of	antibiotic	 inside	the	cells)	and	 increase	the	production	of	enzymes	targeting	the	antibiotics	(impeding	their	functions)	[115].										
	
	
		 27	
	
	
		 28	
	
	
	
	
	
	
Chapter	2:	Major	outer-membrane	protein	
(MOMP)	from	Campylobacter	jejuni	
	
	
	
	
	
Chapter	2:	Major	outer-membrane	protein	from	Campylobacter	jejuni		
	 29	
2.1	Introduction	
	
2.1.1	Campylobacter:	an	overview		
	First	 isolated	 in	 1913	 from	 an	 aborted	 lamb,	 Campylobacters	 were	 originally	wrongly	classified	in	the	genus	Vibrio	(Vibrio	fetus),	and	they	were	subsequently	identified	as	a	new	genus	(Campylobacter)	in	1973	[127].	To	date	15	species	and	6	subspecies	(both	commensal	and	pathogenic)	have	been	annotated	[128].		
	
Campylobacter	 spp.	 are	 gram-negative	 bacteria	 belonging	 to	 the	 class	 of	 ε-proteobacteria	 [129].	 Usually	 spiral	 or	 curve	 shaped,	 Campylobacter	 spp	 are	motile	by	means	of	a	single	or	bipolar	flagellum	[129].	They	belong	to	the	group	of	microaerophilic	and	thermophilic	bacteria,	meaning	that	a	modified	atmosphere	with	 a	 low	 concentration	 of	 oxygen	 and	 a	 high	 concentration	 of	 CO2,	as	well	 as	high	 temperatures	 (37-44°C),	are	necessary	 for	optimal	growth	 [6],	 [131],[132].	Growth	at	lower	temperatures	has	been	proven	to	be	slow	[132].			Particular	metabolic	characteristics	distinguish	Campylobacter	 from	other	gram-negative	 bacteria	 [133],[134].	 Campylobacter	 species	 are	 incapable	 of	 using	glucose	 or	 other	 carbohydrates	 as	 sources	 of	 energy	 due	 to	 the	 lack	 of	 the	glycolytic	 enzyme	 6-phosphofructokinase	 [135].	 Thus,	 organic	 acids,	 as	 well	 as	amino	acids,	such	as	serine,	proline	and	glutamic	acid	represent	their	main	source	of	 energy	 [136][137][138].	 In	 certain	 strains	 of	 C.	 jejuni,	 however,	 an	 L-fucose	pathway	 has	 been	 identified	 but	 not	 yet	 fully	 characterized	 [139].	 Accordingly,	gluconeogenesis	 appears	 to	 be	 fundamental	 for	 the	 production	 of	 glucose	 and	
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glucose-derivatives	 that	 are	 essential	 for	 lipopolysaccharide	 (LPS)	 and	 capsule	biosynthesis	and	hence	campylobacter	virulence	[134].		
2.1.2	Campylobacter	jejuni	infection			C.	jejuni	 and,	 to	a	 lesser	extent,	Campylobacter	coli	have	been	recognized	as	 the	main	 cause	 of	 bacterial	 gastroenteritis	 (campylobacteriosis)	 in	 both	 developed	and	 undeveloped	 countries	 [140],[141],[142].	 In	 recent	 years,	 other	
Campylobacter	 species,	 including	 C.	 concisus,	 C.	 ureolyticus,	 C.	 upsaliensis	 and	 C.	
lari,	have	been	associated	with	gastrointestinal	infections	and	have	been	classified	as	“emerging	pathogens”	[143].	Although	C.	jejuni	has	been	isolated	from	a	wide	range	of	organisms,	avians	(poultry	 in	particular)	are	considered	to	be	the	main	reservoir	 [144].	 Undercooked,	 contaminated	 poultry	 represents	 the	 primary	source	 for	 human	 infections.	 Contaminated	 water	 and	 unpasteurized	 milk	 can	also	 lead	 to	 infections,	 while	 human-to-human	 contamination	 is	 rare	 [145].	Motility,	cell	adhesion	and	cell	 invasion	are	critical	 factors	 that	mediate	C.	jejuni	virulence.	 In	 particular,	 the	 flagellum	 plays	 a	 central	 role	 in	 host	 colonization	[146].	 Classified	 as	 a	 Type	 3	 secretion	 system	 (T3SS),	 this	motile	 structure	 has	been	 shown	 to	 be	 responsible	 for	 the	 secretion	 of	 virulence	 factors	 inside	 the	cytosol	of	 its	host	 [147].	Additionally,	 several	proteins	 located	on	 the	surface	of	the	 bacteria	 contribute	 to	 the	 adhesion	 to	 the	 epithelium,	 enhancing	 C.	 jejuni	virulence	 [148].	Usually	 the	symptoms	of	 the	 infection	arise	within	3	days	after	ingestion	 of	 contaminated	 food,	 with	 symptoms	 lasting,	 on	 average,	 5-6	 days.		Commonly,	 people	 (in	 most	 cases	 children)	 infected	 with	 C.	 jejuni	 experience	
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abdominal	 cramps,	 bloody	 or	 watery	 diarrhea,	 weight	 loss	 and	 fever	 [144].	
Campylobacter	 infections	 are	 normally	 self-limiting,	 however,	 in	immunocompromised	 patients,	 or	 when	 the	 symptoms	 persevere,	 the	 use	 of	antibiotics	 is	 required.	 Untreated	 campylobacteriosis	 can	 progress	 to	 irritable	bowel	diseases	 (IBDs)	such	as	Crohn’s	 syndrome	and	ulcerative	colitis	 [149].	 In	rare	cases,	 infected	 individuals	can	also	develop	paralysis	 through	Guillan-barre	syndrome	(GBS)	or,	its	related	form,	Fisher	syndrome	(FS)	[150],[151],[152].		GBS	is	a	neuropathy	affecting	the	peripheral	nerves,	leading	to	paralysis	of	the	lower	and,	 occasionally,	 the	 upper	 part	 of	 the	 body.	 GBS	 preceded	 by	campylobacteriosis	 is	 caused	 by	 a	 so-called	 molecular	 mimicry	 mechanism	[153][154][155].	 This	 is	 due	 to	 the	 fact	 that	 the	 lipooligosaccharide	 (LOS)	structure	of	C.	jejuni	resembles	the	organization	of	the	human	ganglioside	(Figure	2.1).	 Therefore	 during	 the	 infection,	 antibodies	 against	C.	 jejuni	 can	 cross	 react	with	the	peripheral	nerves	resulting	in	their	demyelization	[153].	Recent	studies	have	also	suggested	that	components	of	C.	jejuni	capsule	and	heat	shock	proteins	(HSP)	might	have	a	role	in	GBS	susceptibility	associated	with	C.	jejuni	[156].								
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Figure	 2.1:	 Mimicry	 mechanism	 in	 GBS	 associated	 to	 C.	 jejuni.	 Schematic	representation	of	human	ganglosides	GM1	and	C.	jejuni	LOS.	Figure	adapted	from	[29].							
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2.1.3	Campylobacter	jejuni	antibiotic	resistance		Antibiotic	 resistance	 in	C.	 jejuni	 has	 become	 a	 real	 concern	 in	 public	 health.	 As	
Campylobacter	 contamination	 among	 people	 is	 rare,	 the	 use	 of	 antibiotics	 in	animal	 farming	is	considered	to	be	the	main	cause	of	resistance	[157].	Although	the	European	Union	has	prohibited	the	addition	of	antibiotics	 in	animal	feed	for	non-therapeutic	purpose	(i.e.	growth	promotion	of	livestock),	in	other	part	of	the	world,	 the	 use	 of	 antibiotics	 as	 growth	 agents	 is	 still	 allowed	 [158].	 C.	 jejuni	strains	 isolated	 from	 contaminated	 poultry	 have	 shown	 resistance	 to	 different	classes	of	antibiotics	such	as	fluoroquinolone	(FQ),	macrolide	[159],	β-lactam	and	tetracycline	 [160][161][162]	 (Figure	 2.2).	 A	 multi-drug	 resistance	 (MDR)	phenotype	has	also	been	observed	[163][164].	The	macrolide	erythromycin	(Ery)	is	used	as	first	choice	treatment	when	campylobacteryosis	is	diagnosed.	However,	as	 campylobacteryosis	 is	 indistinguishable	 from	 other	 enteric	 infections,	Ciprofloxacin	 –	 an	 FQ	 with	 a	 broad	 spectrum	 activity	 against	 Gram-negative	bacteria	–	is	often	preferred	[160].		Antibiotic	 resistance	 in	C.	jejuni	 (as	 in	other	bacteria)	 is	 caused	mainly	by	 three	mechanisms:	 (i)	 Low	 OM	 permeability	 (ii)	 target	 alteration	 (ribosome,	 gene	mutation)	 and	 (iii)	 active	 efflux	 of	 antibiotics	 (CmeABC)[165],[166],[167].	Most	antibiotics	 enter	 the	 cell	 via	 non-specific	 porins.	 In	 general,	 porins	 govern	 the	translocation	of	 antibiotics	depending	on	 the	 charge	 and	 the	 size	of	 their	pores	[14].	In	E.	coli,	two	outer	membrane	proteins,	OmpC	and	OmpF	are	predominant.	In	 resistant	 clinical	 isolates,	 expression	 of	 OmpF	 (higher	 conductance)	 is	 down	regulated	 whilst	 expression	 of	 OmpC	 (lower	 conductance)	 is	 up	 regulated,	
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therefore	 translocation	 of	 antibiotics	 is	 decreased	 [125].	 Unlike	E.	 coli,	C.	 jejuni	has	 only	 one	 major	 outer	 membrane	 protein	 (MOMP),	 which	 has	 a	 molecular	weight	 limit	 of	 360	 Da,	 thus	 molecules	 with	 higher	 molecular	 weight	 cannot	permeate	 inside	 the	 cell	 [168].	 Additionally,	 being	 cationic	 selective,	 MOMP	represent	a	barrier	for	translocation	of	anionic	antibiotics	[168].		
	
Figure	 2.1:	 C.	 jejuni	 antibiotic	 resistance.	 Schematic	 representation	 of	 C.	 jejuni	mechanisms	of	antibiotic	resistance.				
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2.1.4	Major	outer	membrane	protein	(MOMP)	
	In	the	early	80’s,	Logan	and	Trust	identified	a	putative	porin	encoded	by	PorA,	of	an	 apparent	 molecular	 weight	 of	 45	 KDa	 located	 in	 the	 outer	 membrane	 of	 C.	
jejuni	[169].	This	protein	was	largely	expressed	in	the	OM,	and	therefore	named	as	major	outer	membrane	protein	(MOMP).	Predictions	of	 the	 tertiary	structure	suggested	 that	MOMP	resembled	 the	 typical	architecture	of	an	outer-membrane	porin,	 with	 an	 18	 β-strands	 barrel	 connected	 by	 loops	 and	 turns	 [170].	 The	presence	of	β-sheets	structures	was	suggested	by	circular	dichroism	(CD)	analysis	[171],[172].	Additionally,	examination	of	the	amino	acid	composition	showed	that	MOMP	was	comparable	to	the	two	major	porins	in	E.	coli,	OmpC	and	OmpF.	The	N-terminal	of	MOMP,	however,	displayed	significant	differences	[173].	MOMP,	in	vivo,	 adopts	 a	 trimeric	 arrangement,	 as	 shown	 in	 electron	 microscopic	 (EM)	experiments	[174].	In	solution,	detergents	and	temperature	have	been	suggested	to	 influence	 oligomerization.	 Extraction	 with	 increasing	 concentrations	 of	 SDS	and	heating	over	60	°C	leads	to	dissociation	of	the	trimer	into	folded	monomers.	Both	 folded	monomer	 and	 the	 trimer	 can	 be	 identified	 by	 SDS-PAGE	 at	 35	 kDa	and	 140	 kDa,	 respectively.	 Increasing	 the	 temperature	 up	 to	 96	 °C	 has	 been	shown	to	cause	a	shift	from	a	folded	to	an	unfolded	monomer,	which	is,	 instead,	identified	at	45	kDa	[171].	A	similar	behavior	was	described	for	the	trimeric	porin	PhoE	from	E.	coli[175].	Both	oligomeric	states	displayed	pore	activity	when	tested	in	 single	 channel	 experiments	 (with	 a	 conductance	 of	 400	 pS	 for	 the	monomer	and	1200	pS	for	the	trimer)	[176].	In	vitro,	MOMP	has	been	shown	to	participate	in	the	adhesion	of	C.	jejuni	to	human	epithelial	cells	[177],[178],[179].		
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Surface	 exposed	 antigens	 stimulate	 the	 immune	 system	 to	 produce	 antibodies	[180].	 In	 chicks,	 maternal	 antibodies	 have	 been	 proven	 to	 serve	 as	 protection	against	 C.	 jejuni	 infections	 [181].	 This	 inspired	 the	 idea	 to	 use	 C.	 jejuni	 surface	proteins	as	a	target	to	develop	vaccines.	However,	 in	chickens	and	mice	models,	immunization	 using	 CmeC	 subunit,	 the	 lipoprotein	 CjaA	 and	 PEB1	 antigen	 (all	surface-exposed	 proteins),	 have	 failed	 to	 protect	 from	 C.	 jejuni	 colonization	[182],[183],[184].	On	the	contrary,	MOMP-derived	vaccines	have	shown	promise.	MOMP	 contains	 antigenically	 variable	 regions	 at	 the	 level	 of	 the	 loops	 and	conserved	 regions	 present	 in	 the	 β-strands	 [170].	 Islam	 and	 co-workers	 have	already	 shown	 the	 protective	 effect	 of	 a	 recombinant	 MOMP-vaccine	 tested	 in	mice	models[185].	This	study	can	be	used	as	a	starting	point	to	generate	a	vaccine	for	 human	 use.	 Given	 that	 C.	 jejuni	 live	 attenuated	 vaccines	 could	 potentially	trigger	 auto-immune	 diseases,	 the	 use	 of	 a	 MOMP-derived	 vaccines	 would	represent	a	safer	alternative.	
2.1.5	Aims	
	Although	MOMP	 from	C.	 jejuni	 has	 been	 extensively	 studied	 over	 the	 last	 three	decades,	 only	 recently	 its	 crystal	 structure	 has	 became	 available	 (the	 structure	was	 solved	 by	Dr.	 Gregor	Wallat	 for	Naismith’s	 lab).	 Being	C.	 jejuni	 a	 fastidious	organism	to	cultivate,	Dr.	Wallat	successfully	over-expressed	and	purified	MOMP	from	E.	coli.			However,	 the	LPS	of	C.	 jejuni,	 differs	 from	 the	one	of	E.	coli,	with	a	 smooth	or	a	rough	O-antigen	phenotype.	To	address	concern	about	the	effect	of	the	LPS	on	the	
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organization	of	the	MOMP	structure,	we	set	up	to	purify,	solve	the	X-ray	structure	of	 MOMP	 natively	 expressed	 in	 C.	 jejuni	 and	 to	 compare	 it	 to	 the	 structure	obtained	by	Dr.	Wallat.	We	also	aimed	 to	 functionally	 characterize	MOMP	(both	native	and	recombinantly	expressed)	and	explore	the	role	of	the	calcium	found	at	the	constriction	zone	of	MOMP.	(Dr	Wallat	solved	the	structure	at	the	end	of	his	PhD,	no	analysis	was	carried	out).																		
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2.2	Material	and	Methods		
2.2.1Campylobacter	jejuni	culture	
	
Campylobacter	 jejuni	85H	 strain	 [45]	was	 grown	 according	 to	Bolla	 et	al.	 [171].	The	C.	jejuni	strain	was	spread	onto	a	blood	agar	plate	and	incubated	for	24	hours	at	 42	 °C.	 Bacteria	 were	 rinsed	 with	 1	 ml	 of	 2YT	 medium	 and	 agitated	 for	 15	minutes.	 Subsequently,	 250	 µl	 of	 the	 recovered	 bacteria	 were	 spread	 onto	 4	Columbia	 agar	 plates	 supplemented	 with	 the	 appropriate	 amount	 of	
Campylobacter	 selective	 antibiotics	 supplement	 (Oxoid),	 and	 incubated	 for	 48	hours	at	42	°C.	The	plates	were	rinsed	with	1	ml	of	2YT	medium	and	left	rocking	for	 15	 minutes.	 The	 recovered	 bacteria	 were	 subsequently	 inoculated	 onto	 40	plates	of	Columbia	agar	(antibiotic-free)	and	incubated	for	48	hours	at	42	°C.	Each	plate	was	 then	 rinsed	 using	 5	ml	 of	 10	mM	 Tris-EDTA	 (TE)	 buffer	 pH	 7.4	 and	agitated	 for	 15	 minutes	 at	 room	 temperature.	 The	 bacterial	 suspension	 was	recovered	and	 the	OD600	checked	to	be	around	2.	The	bacteria	were	pelleted	by	centrifugation	at	10,000xg	for	30	minutes	at	4	°C.	The	pellet	was	re-suspended	in	200	ml	of	200	mM	Glycine-HCl	pH	2.2	and	agitated	for	15	minutes.	Bacteria	were	harvested	by	 centrifugation	 at	 10,000xg	 for	 30	minutes	 and	washed	 twice	with	100	mM	Tris-HCl	pH	7.4.	Cell	paste	was	then	 immediately	processed	 for	 further	purification	or	stored	at	–80	°C.				
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2.2.2	MOMP	85H	purification	
	Cells	were	re-suspended	 in	300	ml	of	 lysing	buffer	 (Appendix	A.1)	and	 lysed	by	using	 two	 passes	 at	 30	 Kpsi	 through	 a	 high-pressure	 cell	 disruption	 for	 micro	volumes	 (Constant	 System	 Ltd).	 Unbroken	 cells	 were	 removed	 by	 spinning	 the	cell	 lysate	 at	 10,000xg	 for	 30	 minutes	 at	 4	 °C.	 Membranes	 were	 recovered	 by	ultracentrifugation	of	the	supernatant	at	100,000	x	g	for	1	hour	at	4	°C.	The	pellet	was	 then	 homogenized	 in	 10	 mM	 Tris-HCl	 pH	 7.4	 and	 0.1%	 (w/v)	 of	 sodium	lauryl	 sarcosinate	 (Sigma)	 and	 left	 rocking	 for	 30	 minutes	 at	 4	 °C.	 The	 outer	membrane	was	recovered	by	ultracentrifugation	at	100,000xg	for	1	hour	at	4	°C.	The	supernatant	containing	the	inner	membrane	proteins	fraction	was	discarded	and	the	pellet	was	homogenized	with	20	mM	sodium	phosphate	buffer	pH	7.4	and	1%	of	n-octylpolyoxyethylene	(Octyl-POE)	(Bachem	AG)	and	 left	 rocking	at	4	 °C	for	 30	 minutes.	 Solubilized	 outer	 membrane	 proteins	 were	 recovered	 by	ultracentrifugation	at	100,000xg	 for	1	hour	at	4	 °C.	At	 this	 stage,	 the	pellet	was	discarded	 and	 the	 supernatant	 was	 loaded	 onto	 a	 MonoQ	 HR	 ion	 exchange	column	(GE	Healthcare)	and	equilibrated	with	5	column	volumes	(CV)	of	buffer	A	(30	mM	Na2HPO4,	 10	mM	NaCl	 and	0.6%	Octyl-POE).	 The	bound	proteins	were	eluted	stepwise	with	5,	12,	20,	70	and	100%	of	buffer	A	supplemented	with	1	M	NaCl	(Appendix	A.1).	The	chromatography	was	performed	on	ÄKTA	Explorer	10	system	(GE	Healthcare).	Each	fraction	was	examined	with	SDS-PAGE	and	Western	blot	 with	 specific	 antibodies	 to	 test	 both	 purity	 and	 identity.	 Eluted	 fractions	containing	MOMP	were	 collected	 and	 concentrated	 to	 5	ml	 and	 injected	 onto	 a	Superdex	200	16/60	GL	(GE	Healthcare)	column	equilibrated	with	2	CV	of	10	mM	Tris-HCl	pH	8.0,	150	mM	NaCl	and	0.45%	(w/v)	of	tetraethylene	glycol	monooctyl	
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ether	 (C8E4)	 (Bachem).	 Fractions	 containing	 MOMP	 were	 combined	 and	concentrated	to	10	mg	ml-1.		
2.2.3	MOMP	85H	crystallization		
	Initial	 crystallization	 trials	 were	 carried	 out	 using	 several	 commercial	 screens	(Appendix	 B).	 The	 screens	 were	 dispensed	 into	 a	 96-well	 sitting	 drop	 plate	(Intelli-Plate®,	ARI)	using	a	Gryphon	robot,	at	a	protein:reservoir	ratio	of	1:1	and	1:2.	First	hits	appeared	within	a	week.	Crystals	were	manually	optimized	by	the	hanging-drop	vapor	diffusion	technique.			MOMP	85H	was	crystallized	in	0.05	M	calcium	chloride,	0.05	M	barium	chloride,	0.1	M	Tris-HCl	pH	7.5	and	32%	(v/v)	PEG	400.	Different	 ranges	of	pH	and	PEG	concentrations	were	 tested	 in	 order	 to	 obtain	 larger	 crystals.	 The	 best	 crystals	grew	in	0.05	M	calcium	chloride,	0.05	M	barium	chloride,	0.1	M	Tris-HCl	pH	8	and	30%	(v/v)	PEG	400	(Table	2.1).	Crystals	were	harvested	and	flash	cooled	in	liquid	nitrogen	prior	data	collection.	No	cryoprotectant	was	added.					
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Table	2.1.	Optimization	of	MOMP	crystallization	conditions.	
	
	
	
2.2.4	Data	collection,	Structure	determination	and	refinement	
	X-ray	data	 from	a	crystal	of	MOMP	purified	 from	C.	jejuni	85H	were	collected	 in	house	 using	 a	 Rigaku	 Micromax™-007HF	 Cu	 anode	 with	 VariMax	 optics	 and	 a	Rigaku	 Saturn	 944+CCD	 detector	 and	 processed	with	 Xia2	 [186].	 The	 structure	was	 solved	 to	 a	 resolution	 of	 2.9	 Å	 by	 molecular	 replacement	 using	 the	recombinant	 MOMP	 structure	 (PDB	 code:	 5LDV)	 as	 a	 search	 model	 using	 the	program	 MR	 Phaser	 [187]	 .	 The	 model	 was	 manually	 built	 in	 Coot	 [188]	 and	refined	with	REFMAC5	 [189].	 Eventually,	 15	 TLS	 groups	were	 used	 in	 the	 final	refinement	cycle.	The	webserver	“CheckmyMetal”	[190]	was	used	to	validate	the	presence	of	calcium	molecules	at	the	constriction	zone	of	the	protein.				
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2.2.5	Single	channel	conductance	measurements	of	MOMP		
	A	planar	 lipid	bilayer	was	 formed	using	 the	 solvent	 free	 lipid	bilayer	 technique	[191].	 Briefly,	 the	 cuvettes	 used	 for	 experiments	 consist	 of	 two	 separate	chambers,	named	cis	 and	 trans.	A	25-µm	thick	Teflon	 film	(Goodfellow)	with	an	aperture	of	40–100	µm	diameter	is	located	in	between	the	chambers	(Figure	2.3).	The	 aperture	 in	 the	 Teflon	 film	 was	 made	 by	 using	 a	 high	 voltage	 cathode	discharge	(ElectrotechniProducts).	The	aperture	was	pre-painted	with	1	µl	of	1%	hexadecane	 in	 hexane	 using	 a	 pipette	 tip.	 The	 chambers	 were	 filled	 with	electrolyte	 solution	 consisting	 1	 M	 KCl,	 10	mM	MES	 pH	 6.0	 to	 a	 total	 solution	volume	of	2.5	ml.	Then,	5%	solution	of	diphytanoyl	phosphatidylcholine	(DPhPC,	Avanti	Polar	Lipids)	was	added	to	both	chambers.	At	this	point,	the	solution	was	slowly	pipetted	up	and	down	 to	allow	 the	 formation	of	 the	bilayer.	 	MOMP	was	added	 to	 the	 cis	 side	 (which	 is	 the	 electrical	 ground)	 of	 the	 chamber	 at	 a	 final	concentration	 of	 2-3	 ng	 ml-1	 and	 the	 channel	 insertion	 was	 eased	 by	 quickly	mixing	 the	solution	contained	 in	 the	chamber	while	applying	a	 trans-membrane	potential	of	–199	mV.	Electrical	recordings	were	made	through	a	pair	of	Ag/AgCl2	electrodes	(World	Precision	Instruments)	attached	to	an	Axon	Instruments	200B	amplifier	(Axon	Instruments	Inc.).	A	low	pass	Bessel	filter	at	10	kHz	was	used	to	filter	the	data	and	saved	with	a	sampling	frequency	of	50	kHz.	Data	analyses	were	performed	using	Clampfit	10.0	software	(Axon	Instruments	Inc).			Single	channel	measurements	were	also	performed	 in	presence	of	divalent	 ions.	In	this	case,	the	buffer	was	supplemented	with	10	mM	of	CaCl2,	MgCl2	or	ZnCl2.		
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Additionally,	measurements	were	taken	in	the	presence	of	10	mM	of	the	chelating	agent	ethylene	glycol-bis	(β-aminoethyl	ether)-N,N,N',N'-tetraacetic	acid	(EGTA).	The	protein	was	incubated	overnight	with	10	mM	EGTA.			
	
Figure	2.2:	Single	channel	experiments	cuvette.	Picture	of	the	cuvette	used	for	single	channel	 experiments.	On	 the	 left	 particular	 of	 the	Teflon	 film	 aperture	 placed	between	the	two	chambers.									
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2.3	Results	
	
2.3.1	Campylobacter	jejuni	85H	culture	preparation		
Campylobacter	 jejuni	 bacteria	were	 spread	 onto	 selective	 blood-agar	 plates	 and	grown	under	microaerophilic	 condition	 at	 42	 °C.	 	 At	 an	OD600	of	 2,	 the	 bacteria	were	 harvested	 by	 centrifugation.	 Due	 to	 a	 particular	 pigment	 produced	 by	Campylobacter,	the	cell	paste	displayed	a	pink	coloration.			
2.3.2	MOMP	extraction	and	purification		
	MOMP	from	the	native	Campylobacter	jejuni	was	purified	as	described	in	Bolla	et	
al.	 [173]	and	yielded	1	mg	of	protein	per	3	g	of	cell	paste.	A	canonical	 two	step	extraction	 protocol	 was	 used	 in	 order	 to	 separate	 inner	 and	 outer-membrane	proteins.	 MOMP	 purification	 was	 carried	 out	 using	 an	 anion-exchange	chromatography	followed	by	size	exclusion	chromatography.	The	anion-exchange	chromatogram	 showed	 two	 peaks	 eluting	 at	 22%	 and	 70%	 buffer	 B.	 Fractions	from	both	peaks	were	run	on	an	SDS	PAGE,	and	visualized	using	Coomassie	blue	stain.	The	SDS-PAGE	 showed	 that	 the	 expected	 two	bands,	 at	 45	kDa	and	at	50	kDa,	were	present	in	the	fractions	eluting	at	22%	buffer	B	(Figure	2.4	A	lane	1-4).	Mass-spectrometry	analysis	identified	the	band	at	45	kDa	as	MOMP,	and	the	band	at	 50kDa	 as	Omp50	 (see	 chapter	 3).	 The	majority	 of	MOMP,	 however	 eluted	 at	70%	buffer	B	 (Figure	2.4	A	 lane	5-9).	Only	 the	 fractions	containing	MOMP	(and	not	 Omp50)	 where	 used	 for	 further	 purification.	 During	 the	 size	 exclusion	chromatography	Octyl-POE	was	exchanged	to	C8E4,	a	more	suitable	detergent	for	
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crystallography	experiments.	The	eluted	protein	was	then	concentrated	to	10	mg	ml-1.	SDS	-PAGE	was	run	to	evaluate	the	purity	of	the	protein	(Figure	2.4	B).	Gel	bands	 were	 sent	 for	 mass	 spectrometry	 (MS)	 to	 confirm	 the	 identity	 of	 the	protein.									
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Figure	 2.3:	 MOMP	 purification.	 (A).	 Profile	 of	 the	 anion-exchange	 chromatography.	Two	peaks	are	present:	one	on	the	left	elutes	at	22%	buffer	B,	and	the	second	on	the	right	elutes	 at	 70%	 buffer	 B.	 (B).	 SDS-PAGE	 of	 chosen	 fractions	 from	 the	 anion-exchange	chromatography.	M	is	the	ladder,	lanes	1-4	show	two	bands:	one	at	50	kDa	(Omp50)	and	one	at	45	kDa	as	confirmed	by	mass	spectrometry.	C.	Profile	of	the	SEC	performed	using	a	16/600	200pg	(GE)	column.	The	elution	volume	of	MOMP	was	compared	to	 the	elution	volumes	of	molecular	weight	(MW)	markers	(Bio-rad)	(used	to	calibrate	the	column)	in	order	 to	analyse	 its	oligomeric	state.	MOMP	was	 found	 to	be	 trimeric.	 (D)	SDS-PAGE	of	chosen	fractions	from	the	SEC.	M	is	the	ladder,	lane	1	is	the	sample	before	SEC	and	lanes	2	to	6	are	fractions	from	the	main	peak.								
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2.3.3	MOMP	crystallization	and	structure	determination		The	MOMP	crystals	appeared	after	 three	days.	Crystals	were	 found	 in	condition	B3	 of	 the	 Mem	 Gold	 I	 crystallization	 screening	 (Molecular	 dimension).	 After	optimization	 using	 the	 hanging	 drop	 vapor	 technique,	 the	 largest	 crystals	were	found	in	0.05M	Calcium	chloride,	0.05	M	barium	chloride,	0.1	M	Tris-HCl	pH	8.5	and	30%	PEG	400	(Figure	2.5).	The	crystals	were	analyzed	with	an	in	house	X-ray	source	and	found	to	diffract	to	2.9	Å.	A	dataset	was	collected	and	processed	using	Xia2	 [186]	 in	 the	 space	 group	 P212121.	 Analysis	 of	 the	 Matthew’s	 coefficient	(Matthew’s	coefficient	of	2.64)	suggested	that	three	molecules	were	present	in	the	asymmetric	unit	(AS).	The	structure	was	solved	by	molecular	replacement	using	MR	 Phaser	 from	 the	 CCP4	 suite	 [187].	 As	 search	 model	 was	 used	 the	recombinantly	expressed	MOMP	(PDB	code:	5LDV).	The	quality	of	 the	structure	was	 assessed	 using	 Molprobity.	 Data	 collection	 and	 refinement	 statistics	 are	shown	in	table	2.2.			
	
Figure	 2.4:	MOMP	 crystals.	Crystals	of	MOMP	under	visible	 light.	Crystals	grew	using	hanging	drop	vapor	technique.	
300μm	 300μm	
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Table	2.2.	Data	collection,	refinement	and	validation	statistics.	Space	group	 P212121	Cell	dimensions	a,b,c	(Å)	 94.4,	99.4,172.2	Cell	dimensions	α,β,γ	(°)	 90,	90,	90	Resolution	(Å)	 47.75-2.9(3.06-2.9)	Rmerge	 0.14	(0.86)	Completeness	(%)	 99.9	(99.8)	Multiplicity	 7.3	(7.2)	I/σ(I)	 12.9	(3.0)	
CC	1/2	 0.9	(0.7)	
	
Refinement	
	
	
Rfactor/Rfree	(%)	 23.9/27.1	N°	of	unique	reflections	 36693	N°	of	residues	 405	Water	 5		
Rmsd		 	Bonds	length	(Å)	 0.01	Bonds	angles	(Å)	 1.9	
	
MolProbity	
		
	
Ramachandran	outliers	(%)	 0	Ramachandran	favored	(%)	 95.41	Clash	score	 1.7		Molprobity	score	 1.68		
	
*(Values	in	parentheses	are	for	the	highest-resolution	shell)						
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2.3.4	Crystal	structure	of	MOMP		MOMP	 is	 a	 homotrimer	 composed	 of	 18-β-stranded	 monomers,	 with	 a	characteristic	 elliptical	 shape.	 Each	 monomer	 consists	 of	 405	 amino	 acids.	Common	 for	 porins,	 the	 β-strands	 (β)	 are	 linked	 together	 by	 long	 extracellular	loops	 (L)	 and	 short	 periplasmic	 turns	 (T)	 (Figure	 2.6	 A).	 As	 predicted	 by	 the	software	 SignalP	 4.0	 [192],	 the	 signal	 peptide	 of	 the	 native	MOMP	was	 cleaved	between	 Ala22	 and	 Thr23.	 Consequently,	 the	 Thr23	 is	 the	 first	 residue	 in	 the	tertiary	structure	and	as	such	was	renumbered	to	Thr1.				L3,	L4,	L6	fold	back	inside	the	barrel	forming	the	so-called	constriction	zone		(Figure	 2.6	 B).	 As	 is	 common	 for	 porins,	 the	 constriction	 zone	 of	 MOMP	 is	characterized	of	negatively	charged	residues	(located	in	the	L3)	interacting	with	positively	 charged	 residues	 located	 in	 the	wall	 of	 the	 barrel,	 at	 the	 front	 of	 the	loop.	 L2	 is	 involved	 in	 the	 stabilization	 of	 the	 trimer.	 Accordingly,	 analysis	performed	using	the	web	server	PDBePISA	showed	that	several	hydrogen	bonds	were	formed	between	L2	and	the	β-	sheets	of	the	adjacent	monomer,	in	particular	with	β4,	β5,	β6	and	β7.		
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Figure	 2.5:	 Crystal	 structure	 of	 MOMP.	 (A)	 Cartoon	 of	MOMP	 trimer	 view	 from	 the	extracellular	space	(left)	and	from	the	side	(right)	of	the	membrane.	The	three	chain	are	colored	 in	 magenta,	 green	 and	 cyan.	 (B)	 Monomer	 of	 MOMP,	 with	 highlighted	 loops	involved	 in	 the	 formation	of	 the	constriction	zone	and	L2.	L3	 is	 colored	 in	green,	L4	 in	orange,	L6	in	cherry	red	and	L2	in	purple.	Major	and	minor	axis	measure	approximately	37	and	19	Å,	respectively.							
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8	amino	acids	(Thr1	to	Lys8)	at	the	N-terminus	form	an	α-helix	that	points	away	from	 the	 barrel	 wall,	 toward	 the	 adjacent	 monomer.	 In	 this	 way,	 the	 three	 α-helices	(one	for	each	monomer)	form	a	triangle	that	faces	the	periplasmic	space	(Figure	2.7).			
	
Figure	 2.6:	 N-terminus	 of	 MOMP.	 (A)	 In	 grey	 is	 depicted	 the	 MOMP	 monomer,	 in	magenta	the	N-terminus.	(B)	Periplasmic	view	of	the	N-terminus	complex	(color	scheme	as	in	2.5)	in	MOMP	trimer.								
A.	 B.	
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2.3.5	The	electrostatic	potential	of	MOMP		
	The	electrostatic	potential	of	MOMP	was	analyzed	using	CCP4mg	program	[193].	The	 eyelet,	 viewed	 from	 the	 extra-cellular	 (EX)	 (Figure	 2.8	 A)	 and	 periplasmic	(PE)	 (Figure	 2.8	 B)	 side,	 exhibited	 a	 clear	 separation	 of	 positive	 and	 negative	charges	with	Asp116	(L3),	Asp	120	(L3)	and	Asp155	(L4)	facing	Arg17,	Arg19	and	Lys43	on	the	opposite	side.		Both	 the	 extra-cellular	 loops	 and	 the	 periplasmic	 turns	 of	 MOMP	 displayed	charged	 residues	 (positive	 and	 negative),	 whereas	 the	 outside	 of	 the	 barrel,	 as	expected	 for	 proteins,	 embedded	 in	 a	 hydrophobic	 lipidic	 bilayer	 and	 was	uncharged	(Figure	2.8	C-D).				
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Figure	2.7:	Electric	potential	of	MOMP.	(A)	View	of	the	channel	from	the	extra-cellular	space.	In	the	black	circle	is	a	zoom	in	of	the	eyelet.	The	charged	amino	acids	forming	the	eyelet	are	in	sticks.	(B)	View	of	the	channel	from	the	periplasmic	space.	(C)	View	of	the	channel	from	the	side.	(D)	View	of	the	trimeric	MOMP	from	the	extra-cellular	space.										
C.	
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2.3.6	Calcium	binding	sites	in	MOMP	
		Two	calcium-binding	sites	were	identified	in	MOMP,	one	inside	the	channel	at	the	level	 of	 the	 constriction	 zone,	 and	 the	 other	 one	 outside	 the	 β-barrel	 at	 the	interfaces	between	monomers	(Figure	2.9	A).	At	the	constriction	zone,	the	metal	ion	is	coordinated	by	the	residues	Asp120	(L3)	(oxygen	and	side	chain),	Gln152	(L4),	Asp155	(L4),	and	Glu288	(L6).	A	water	molecule	fills	the	last	position	and	is	in	 turn	 coordinated	 by	 Asp116	 (L3)	 and	 Asp289	 (L6).	 The	 ion	 has	 a	 typical	octahedral	coordination	and	creates	a	bond	across	L3,	L4	and	L6	(Fig.	2.9	B).	The	second	calcium	 ion	 is	 instead	coordinated	by	 the	residues	Asp145	(β6)	 (oxygen	and	side	chain),	Asn180	(L4)	and	Gly72	and	Asp77	(both	L2)	 from	the	adjacent	monomer	(Figure	2.9	C).	The	webserver	CheckmyMetal	confirmed	the	presence	of	both	the	calcium-binding	site	[190]	(Table	2.3).					
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Figure	 2.8:	 Calcium-binding	 sites	 in	MOMP.	 (A)	Extra-cellular	 view	of	MOMP	 trimer	and	 the	 calcium	binding	 sites.	 Theβ-barrel	 is	 colored	 in	 cyan,	 the	 loop	 in	 sand	 and	 the	calcium	molecules	 in	purple.	Zoom	in	of	 the	calcium-binding	site	 inside	the	channel	(B)	and	between	monomers.	(C)	The	amino	acids	involved	in	the	binding	are	shown	in	sticks.	Calcium	is	colored	in	purple	and	water	in	red.	(D)	F0-F2	and	2F0-F2	electron	density	map	at	5σ	and	2σ,	respectively,	of	the	amino	acids	involved	in	the	calcium	binding	site	at	the	constriction	zone.	Calcium	is	colored	in	purple	and	water	in	red.			
A.	 B.	
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Table	2.3.	Bond	distances	of	the	two	calcium	binding	sites	in	MOMP.	
	
	
2.3.7	Single	channel	conductance	measurements		MOMP	 conductivity	 was	 assessed	 by	 single	 channel	 measurements	 in	 10	 mM	Hepes	pH	6	and	1	M	KCl.	MOMP	was	randomly	inserted	into	the	bilayer	as	either	a	monomer	 or	 a	 trimer.	 Consequently,	 we	 detected	 two	 different	 levels	 of	conductance,	a	lower	one	of	0.7	±	0.2	nS,	and	a	higher	one	of	2.2	±	0.2	nS.	These	corresponded	 to	 the	monomeric	 and	 trimeric	 states,	 respectively.	The	 electrical	signature	showed	that	at	negative	voltages,	long	upward	spikes	occurred	for	both	
	 Interacting	molecule	 Bond	length	(Å)	
Calcium	binding	site	at	the	constriction	zone	Asp120	(Oxygen	 and	 side	chain)	 Ca2+	 2.33/2.29	Gln152	 Ca2+	 2.32	Asp155	 Ca2+	 2.32	Glu288	 Ca2+	 2.31	H2O	 Ca2+	 2.49	
Calcium	binding	site	in	between	monomers	Asp145		(Oxygen	 and	 side	chain)	 Ca2+	 2.29/2.3	Asn180	 Ca2+	 2.26	Gly72	 Ca2+	 2.27	Asn77	 Ca2+	 2.32	
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monomeric	 and	 trimeric	 MOMP.	 In	 contrast,	 at	 positive	 voltages,	 while	 the	monomer	 trace	was	 noisy	 (displaying	 long	 downward	 spikes),	 the	 trimer	 trace	was	silent	(Figure	2.10).			
	
Figure	2.9:	Single	channel	recording	of	MOMP.	Electric	trace	of	(A)	MOMP	monomer	and	(B)	MOMP	trimer	at	+100	mV	(right)	and	at	-100	mV	(left).			To	elucidate	 the	effect	of	Ca2+	on	 the	channel,	 conductance	measurements	were	also	 taken	 in	 presence	 of	 10mM	 CaCl2.	 Interestingly,	 the	 presence	 of	 calcium	eliminates	 the	 long	 spikes	previously	observed	at	negative	voltage.	The	 calcium	makes	the	channel	stable	(at	both	positive	and	negative	voltage)	(Figure	2.11	A).	Measurements	were	also	 taken	after	overnight	 incubation	of	MOMP	with	10mM	of	the	chelating	agent	EGTA	to	remove	the	calcium	(EGTA	was	also	added	to	the	
A.	
B.	
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buffer	at	a	final	concentration	of	10	mM).	Not	surprisingly,	the	electrical	trace	was	silent	at	positive	voltage	but	noisy	at	negative	voltage,	as	with	the	native	protein	(Figure	2.11	B).			In	 a	 control	 experiment,	we	 slowly	 replaced	 the	 buffer	 containing	 EGTA	with	 a	buffer	containing	10	mM	CaCl2.	As	expected	the	calcium	reverted	the	effect	of	the	chelating	agent,	resulting	in	an	entirely	silent	channel.		
Figure	2.10:	 Single	 channel	 recording	 of	MOMP.	Electric	 trace	of	MOMP	trimer	with	(A)	and	without	(B)	at	+100	mV	(right)	and	at	-100	mV	(left).				In	order	to	assess	the	specificity	of	this	effect,	other	divalent	ions	were	tested.	In	
A.	
B.	
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particular,	 conductance	measurements	were	 taken	 in	 the	 presence	 of	 10mM	 of	either	MgCl2	or	 ZnCl2.	Neither	 the	magnesium	nor	 the	 zinc	was	 able	 to	 stabilize	the	 channel.	 At	 negative	 voltage	 the	 channel	 showed	 the	 same	 long	 spikes	detected	in	absence	of	calcium	(Figure	2.12).		
	
Figure	2.11:	Single	channel	recording	of	MOMP.	Electric	trace	of	MOMP	trimer	with	10	mM	MgCl2	(A)	and	10	mM	of	ZnCl2	(B)	at	+100	mV	(right)	and	at	-100	mV	(left).				
A.	
B.	
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2.4	Discussion	
	
2.4.1	MOMP	crystal	structure	
	In	this	study,	we	present	the	first	X-ray	structure	of	the	natively	expressed	MOMP	from	 Campylobacter	 jejuni	 strain	 85	 H.	 Although	 previous	 analysis	 of	 two-dimensional	and	three-dimensional	crystals	of	MOMP	provided	a	clear	indication	of	the	trimeric	arrangement	of	the	protein,	similar	to	that	observed	for	OmpC	and	OmpF	 in	 E.	 coli,	 they	 failed	 to	 give	 complete	 structural	 data	 [194].	 The	 crystal	packing	of	the	structure	we	obtained	confirmed	this	trimeric	arrangement.	Each	monomer-monomer	 interface	 buries	 over	 1200	 Å2	 of	 surface	 area,	 while	 the	trimer	 buries	 almost	 10,000	 Å2	of	 surface	 area.	 Overall,	 the	 structural	 features	observed	 in	MOMP	 are	 common	 to	 all	 the	 porins	 characterized	 so	 far.	 A	 barrel	consisting	of	18-anti-parallel	β-strands	joined	together	by	long	extracellular	loops	and	short	periplasmic	turns.	The	L3	folds	back	inside	the	barrel	to	form	the	eyelet	of	the	pore,	a	region	characterized	of	negatively	and	positively	charged	residues	facing	 each	 other	 that	 create	 a	 strong	 electric	 field.	 L2	 stabilizes	 the	 trimer	 as	suggested	 by	 the	 several	 hydrogen	 bonds	 formed	 with	 the	 β-strands	 of	 the	adjacent	monomers.			A	 distinctive	 feature	 of	MOMP	 is,	 instead,	 the	 α-helix	 at	 the	 N-terminus,	 which	bends	outwards	reaching	the	neighboring	subunit	and	forms	an	α	-helix	triangle.	To	date,	only	two	outer-membrane	proteins	display	such	an	unusual	arrangement	at	 the	 N-terminal:	 OprB	 from	Pseudomonas	aeruginosa	 [195]	 and	 the	 palmitoyl	transferase	PagP	 from	E.	coli	[68]	 (Figure	2.13).	The	helix	 in	 these	 structures	 is	
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not	 involved	 in	 the	 trimerizazion	 since	 both	 proteins	 exist	 as	 monomer.	Interestingly,	 the	 sucrose-specific	 porin	 (ScrY)	 from	 Salmonella	 typhimurium	contains	a	coiled-coil	structure	at	the	N-terminal	domain	[196],[197].	Unlike	PagP	and	OprB,	ScrY	oligomerises	 form	a	homo-trimer.	Spectroscopic	and	biophysical	analysis	 suggested	 that	 the	 ScrY	N-terminus	α-helical	 coiled-coil	 complex	might	be	 involved	 in	 the	 oligomer	 stabilization;	 however,	 no	 structural	 data	 of	 this	domain	are	available	[196].	Although	the	role	of	the	N-terminal	α–helix	in	MOMP	has	yet	to	be	investigated,	PDBePISA	analysis	suggests	it	might	contribute	to	the	stability	of	the	trimer	(Table	2.4).		
	
Figure	2.12:	α-helices	N-terminus.	N-terminus	of	PagP	(A)	and	OprB	(B).	β-barrels	are	colored	in	grey	and	N-terminus	domain	in	pink.	
	
	
A.	 B.	
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Table	 2.4.	 α-helices	 N-terminus	 bond	 distances.	 Measurements	 were	generated	with	PISAePDB.		
Residue	monomer	1	 Residue	monomer	2	 Bond	distance	(Å)	
Val12	(N)	 Thr1	(O)	 2.9	
Val12	(O)	 Thr1	(N)	 3.2	
Val10	 Leu3	 3.1			
2.5.2	MOMP	pore	activity	analysis	in	single	channel	experiments	
	Single	 channel	 measurements	 indicated	 that	 MOMP	 could	 randomly	 insert	 as	either	 a	 monomer	 or	 a	 trimer.	 Previous	 studies	 have	 already	 shown	 that	 in	solution	MOMP	exists	as	both	monomer	and	trimer	depending	on	the	detergents	used	 for	 the	 extractions,	 and	 that	 both	 oligomeric	 states	 exhibit	 pore-forming	activity	 [176].	 The	 trimer	 exhibits	 high	 single	 channel	 conductance	 of	 2.2	 nS	comparable	to	the	E.	coli	osmoporin	OmpC	(2.5	nS)	[198].	In	contrast	to	what	has	been	 reported	 for	MOMP,	 OmpF	 and	OmpC	 have	 shown	 higher	 stability	 and	 in	lipid	bilayer	 insert	solely	as	a	 trimer.	While	at	negative	voltage,	both	monomers	and	trimers	showed	the	same	behavior	(long	downward	spikes),	differences	were	found	when	 a	 positive	 voltage	was	 applied.	 As	 shown	 in	 Figure	 2.9,	 at	 positive	voltage,	the	trimer	was	silent,	where	the	monomer	was	noisy	with	long	upwards	spikes	 However,	 we	 are	 unable	 to	 determine	 if	 the	 monomer	 detected	 during	single	 channel	 experiments	 derived	 from	 a	 trimer	with	 two	 closed	 channels	 or	from	the	dissociation	of	the	trimer	in	single	monomers.		
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2.5.3	Structural	role	of	the	Ca2+	at	the	constriction	zone			A	unique	feature	of	MOMP,	relative	to	the	others	OMPs	is	the	calcium	ion	found	at	the	constriction	zone.	The	calcium	holds	together	a	number	of	key	loops	(L3,	L4	and	L6).	Previous	studies	have	shown	that	addition	of	EDTA	to	the	protein,	which	would	 remove	 any	 calcium,	 destabilizes	 the	 protein	 [172].	 When	 we	 analyzed	MOMP	behavior	in	single	channel	experiments,	we	observed	that	the	addition	of	10	 mM	 CaCl2	 gave	 stable	 electrical	 traces,	 whereas	 EGTA	 addition	 resulted	 in	noisy	conductance	comparable	to	the	native	protein.	In	a	control	experiment,	we	removed	 the	 buffer	 containing	 EGTA	 and	we	 replaced	 it	with	 10mM	CaCl2,	 this	reversed	the	effect	of	the	chelating	agent,	restoring	a	stable	trace.	This	was	metal	specific	 as	 the	 addition	 of	 Mg2+	 or	 Zn2+	 did	 not	 result	 in	 a	 stable	 ion-current	profile.	In	collaboration	with	the	University	of	Cagliari,	we	analyzed	the	structure	in	the	presence	and	in	the	absence	of	calcium.		In	silico	measurements	of	the	root	mean	square	deviation	(r.m.s.d)	and	the	root	mean	square	fluctuation	of	the	loops	(r.m.s.f)	showed	that	in	the	presence	of	calcium,	the	structure	is	significantly	less	flexible	 (r.m.s.d	1.45	Å	vs	1.75	Å).	Unsurprisingly,	when	 the	calcium	 is	 removed	the	 instability	 is	 mainly	 focused	 on	 the	 loops	 involved	 in	 its	 coordination.	Therefore,	we	propose	 that	 its	role	 is	structural	and	 that	 the	binding	of	calcium	anchors	 the	 loops	 (L3,	 L4	 and	 L6),	 hence	 ordering	 the	 eyelet	 preventing	 them	flickering	 into	 the	 pore	 and	 thus	 eliminating	 the	 long	 spikes	 observed	 in	 ion-current	in	the	absence	of	calcium.	
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2.5.4	Functional	role	of	the	Ca2+	at	the	constriction	zone	(Collaboration	with	the	
University	of	Cagliari)	
	Our	collaborators	at	 the	University	of	Cagliari	also	 investigated	 the	effect	of	 the	calcium	on	the	permeation	of	the	polar	antibiotic	ciprofloxacin,	a	FQ	often	used	to	treat	 cambylobacteriosys.	 Dr.	 Silvia	 Acosta-Gutierrez	 calculated	 the	 free	 energy	profiles	for	ciprofloxacin	translocation	for	MOMP	with	and	without	calcium	at	the	constriction	zone.	As	expected,	the	two	free	energy	maps	significantly	differ	at	the	level	 of	 the	 constriction	 zone	 where	 the	 calcium	 is	 bound.	 In	 the	 absence	 of	calcium,	 ciprofloxacin	 points	 at	 the	 constriction	 region	 with	 its	 positive	 group,	towards	the	negatively	charged	amino	acids	that	lie	on	L3.	In	presence	of	calcium,	the	 negative	 charge	 of	 those	 amino	 acids	 is	 shielded	 and	 therefore,	 the	ciprofloxacin	 enters	 in	 the	 opposite	 orientation,	 pointing	 its	 carboxylic	 group	towards	 the	 ion.	 Additionally,	 in	 the	 presence	 of	 calcium,	 an	 applied	 voltage	higher	 than	 +100mV	 is	 required	 to	 allow	 the	 complete	 translocation	 of	ciprofloxacin.	According	 to	molecular	dynamics	analysis,	 the	antibiotic	 follows	a	different	path	and	has	a	higher	barrier	to	translocation	in	the	presence	of	calcium	(Figure	2.13).		Similar	behavior	has	already	been	observed	in	OmpF	from	E.	coli	where	an	ion	of	magnesium	was	 found	bound	at	 the	 level	 of	 the	 constriction	 zone	 [199].	Unlike	MOMP,	however,	OmpF	magnesium	is	just	an	artifact	of	crystallization	conditions.	
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Figure	2.13:	“Most	statistically	relevant	conformations	 for	the	chosen	minima	are	
depicted	 EX,	 CR1	 and	 CR2,	 for	 both	 scenarios.”	 “For	 clarity,	 β-strands	 from	9	 to	 14	have	been	removed	from	the	cartoon	representation	of	MOMP	monomer.	Ciprofloxacin	is	represented	 in	 licorice.	 Interacting	 loops	are	highlighted	 in	orange	and	 labeled.	Specific	charged	residues	 interacting	with	ciprofloxacin	are	shown	 in	 licorice	colored	according	to	its	charge”.	Dr.	Silvia	Acosta-Gutierrez	provided	this	picture	and	the	caption.		
	
2.5.5	Comparison	between	recombinant	and	native	MOMP	
	A	 structure	 of	 MOMP	 recombinantly	 expressed	 in	 E.	 coli	 was	 obtained	 by	 Dr.	Gregor	Wallat	(Prof.	Naismith’s	laboratory).	We	compared	the	two	structures,	the	recombinant	and	the	natively	expressed	MOMP	and,	apart	from	small	differences	arising	 from	 the	 different	 crystal	 packing,	 the	 two	 structures	were	 structurally	identical	(r.m.s.d	0.45	Å	over	398	Cα	position)	(Figure	2.15).	Both	structures	have	a	 Ca2+	 ion	 bound	 at	 the	 constriction	 zone.	 Unlike	 the	 recombinant	 MOMP,	 the	
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natively	 expressed	 protein	 was	 crystallized	 in	 the	 presence	 of	 CaCl2.	 As	 a	consequence,	the	native	structure	has	an	extra	calcium	ion	located	at	the	interface	between	 monomers.	 The	 recombinant	 structure	 shows	 a	 different	 side	 chain	conformation	suggesting	that	 in	the	recombinant	protein	this	site	does	not	exist	and	it	is	an	artifact.		
	
Figure2.14:	 Superimposition	 of	 MOMP	 native	 (cyan)	 and	 MOMP	 recombinant	
(orange).	 View	 from	 the	 side	 (left)	 and	 from	 the	 top	 (right).	 The	 two	 structures	were	found	to	be	structurally	identical	with	a	r.m.s.d	of	0.45	Å	over	398	Cα	position.			
2.5.6	MOMP:	general	or	specific-substrate	porin?	
	As	 a	 general	 rule,	 18	 β-stranded	 porins	 are	 classified	 as	 substrate-specific.	 To	date,	 aside	 from	 MOMP,	 the	 only	 structures	 of	 trimeric	 18	 β-stranded	 porins	available	 are	 the	 structure	 of	 the	 maltoporin	 LamB	 from	 E.coli	 [200]	 and	 the	sucrose-porin	 SrcY	 from	 Salmonella	 tiphymurium	 [33].	 A	 distinctive	 feature	 of	both	LamB	and	SrcY	is	a	cluster	of	aromatic	amino	acids	(greasy	slide)	that	guides	the	 molecules	 of	 sugar	 through	 the	 porin	 channel	 [201],[202],[196].	 Although	
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LamB	and	SrcY	share	only	20%	of	 sequence	homology	 (Protein	Data	Bank),	 the	amino	acids	that	form	the	greasy	slide	are	highly	conserved.	Analysis	of	the	amino	acids	sequence	and	structure	revealed	 that	no	greasy	slide	 is	present	 inside	 the	channel	of	MOMP.	Furthermore,	 taking	 into	account	 the	 fact	 that	C.	 jejuni	 is	not	able	to	use	sugars	as	a	source	of	carbon	[133],	it	is	unlikely	that	MOMP	belongs	to	the	 class	 of	 sugar-specific	 porins.	 Moreover,	 a	 closer	 analysis	 of	 the	 size	 and	charge	of	 the	pore,	as	well	as	 the	conductivity,	 led	to	the	conclusion	that	MOMP	has	a	greater	resemblance	to	a	general	porin	(pore	size	and	conductivity	of	MOMP	lies	in	between	pore	size	and	conductivity	of	OmpC	and	OmpF	from	E.	coli),	rather	than	a	specific	porin.	We	therefore	suggest	that,	although	structurally	different	to	the	 general	 porins	 described	 so	 far	 (18	 β-strand	 rather	 than	 16),	 MOMP	represents	 the	 only	 general	 porin	 expressed	 in	C.	 jejuni.	 In	 addition,	 due	 to	 the	high	level	of	expression	of	MOMP,	we	conclude	that	its	role	may	also	be	structural,	other	than	merely	functional,	contributing	to	the	integrity	of	the	outer	membrane	of	C.	jejuni.			
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2.6	Conclusion	and	outlook		Antibiotic	 resistance	 in	Cambylobacter	 has	 become	 a	 real	 concern.	C.	 jejuni	 is	 a	fastidious	 organism	 that	 represent	 the	 main	 source	 of	 campylobacteriosis	worldwide.	 Unlike	 E.	 coli,	 C.	 jejuni	 has	 only	 one	 major	 porin,	 MOMP,	 highly	expressed	in	the	outer	membrane	(MOMP).	Here	we	present	the	2.9	Å	structure	of	MOMP	natively	expressed	in	C.	jejuni	85	H.	The	structure	showed	that	MOMP	is	an	18	 β-	 stranded	 trimeric	 porin	 with	 two	 calcium	 binding	 sites,	 one	 inside	 the	channel	and	the	other	between	monomers.	While	the	calcium	between	monomers	resulted	 because	 of	 an	 artifact	 of	 the	 crystallization,	 the	 calcium	 found	 at	 the	constriction	 zone	 was	 bound	 during	 expression	 and	 remained	 attached	throughout	the	purification	process.	 In	this	work,	we	proved	that	the	calcium	at	the	constriction	zone	has	both	a	structural	and	 functional	role.	According	to	 the	results	 obtained	 in	 collaboration	 with	 Prof.	 Ceccarelli	 and	 Dr.	 Silvia	 Acosta-Guitierrez	 from	 the	University	of	Cagliari,	 it	 is	possible	 that	C.	 jejuni	 utilizes	 the	ion	 of	 calcium	 to	modulate	 the	 permeations	 of	molecules,	 and	 thus	 antibiotics,	through	the	pore.			Future	work	should	be	carried	out	to	clarify	if	MOMP	is	indeed	a	general	porin	(as	we	believe)	or	a	 substrate-specific	porin.	Also,	 co-crystallization	 trials	of	MOMP	with	chosen	antibiotics	(in	presence	and	absence	of	EDTA)	should	be	attempted	in	 order	 to	 shade	more	 light	 onto	 the	 role	 of	 the	 calcium	 in	 drugs	 permeation.
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3.1	Introduction	
	
3.1.1	Omp50	from	Campylobacter	jejuni	
	Omp50	was	 first	 identified	as	 a	porin	of	C.	 jejuni	 85H	 in	a	 report	by	Bolla	et	al.	[203].	 Omp50	 was	 predicted	 to	 be	 an	 18-β-stranded	 monomeric	 porin.	Electrophysiology	experiments	demonstrated	the	ability	of	Omp50	to	form	a	pore	when	inserted	in	a	lipid	bilayer	[203].	Due	to	the	low	conductivity	(50-60	pS	in	1	M	 NaCl)	 exhibited,	 it	 was	 hypothesized	 that	 Omp50	 could	 represent	 a	 specific	porin	rather	than	a	general	one	[203].			The	 gene	 encoding	 for	Omp50	 (cj1170)	 is	 not	 ubiquitous	 in	Campylobacter	 and	therefore	 is	 used	 to	 differentiate	 Campylobacter	 species	 [204].	 Cj1170	 is	transcriptionally	 regulated	 in	 a	 temperature	 dependent	 manner	 [205]	 and	 up-regulated	in	the	presence	of	the	antibiotic	erythromycin	(Ery)	[206].	The	effect	of	Ery	on	the	up-regulation	of	Omp50	has	been	linked	to	its	proposed	kinase	activity	[206],[207].			Corcionivoschi	et	al.	first	suggested	Omp50	as	a	bacterial	tyrosine	(BY)	kinase	in	
C.	 jejuni	 11168	 strain	 [207].	 BY-kinases	 belong	 to	 a	 subgroup	 of	 kinase	 able	 to	auto-phosphorylate	on	several	 tyrosine	 [208].	Typically	embedded	 in	 the	 inner-membrane,	BY-kinases	consist	of	 two	transmembrane	α-helices	 link	together	by	an	external	loop	(also	known	as	hairpin	loop)	and	of	a	cytosolic	catalytic	domain.	The	 catalytic	 domain	 contains	 three	 different	 motifs:	 Walker	 A,	 Walker	 A’	 and	
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Walker	B	motif.	In	addition	to	the	three	motifs,	a	C-terminus	tyrosine	cluster	(YC)	is	also	found	in	the	catalytic	domain	[208].	Sequence	analysis	of	Omp50	led	to	the	identification	 of	 the	 Walker	 A	 and	 A’	 motifs	 (but	 no	 Walker	 B)	 motifs	 were	identified	in	Omp50	sequence	and	of	one	tyrosine	(Y338)	that	was	reported	to	be	essential	 for	 Omp50	 kinase	 activity.	 Mutation	 of	 this	 tyrosine	 suppressed	 the	tyrosine	kinase	pathway	in	C.	jejuni	1168,	suggesting	that	Omp50	is	the	only	BY-kinase	 in	 this	 organism.	 They	 also	 identified	 the	 enzyme	 UDP-	 GlcNAc/Glc	 4-epimerase	 (Gne)	 as	 one	 of	 Omp50’s	 substrates.	 It	 was	 suggested	 that	 Omp50	positively	regulates	Gne	activity	by	phosphorylating	a	tyrosine	(Y146)	in	its	active	site.	Considering	that	Gne	is	involved	in	the	formation	of	the	lipooligosaccharide	(LOS)	 and	 the	 capsule	 of	C.	 jejuni,	 Omp50	 kinase	 activity	 has	 been	 proposed	 to	have	 an	 impact	 on	 the	 permeability	 of	 the	 outer-membrane	 and	 therefore	 on	antibiotic	permeation.			
3.1.2	Aims		Omp50	 is	 a	 monomeric	 porin	 associated	 to	 antibiotics	 (especially	 macrolides)	resistance	in	C.	jejuni	[206].	To	date	no	structural	data	about	Omp50	are	available.		We,	therefore,	aimed	to	solve	the	structure	of	Omp50	using	X-ray	crystallography.	In	 order	 to	 do	 so,	 we	 first	 set	 up	 to	 purify	 Omp50	 from	 the	 native	 C.	 jejuni,	However,	due	 to	 the	 low	yield	obtained	we	decided	 to	 switch	 to	 a	 recombinant	system.	 We	 also	 set	 up	 to	 analyze	 the	 pore	 activity	 of	 the	 recombinantly	expressed	Omp50	in	lipid	bilayer	by	using	electrophysiology	measurements,	and	ultimately	compared	it	to	the	natively	expressed.	
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	Following	 the	 publication	 of	 Corcionivoschi	 et	 al.	 [207],	 we	 also	 aimed	 to	investigate	 the	proposed	kinase	activity	of	Omp50	with	both	 the	 recombinantly	and	native	expressed	protein.																						
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3.2	Material	and	methods	
	
3.2.1	Omp50	purification	from	the	native	C.	jejuni	85H	and	11168	strain	
	
C.	jejuni	cultures	were	prepared	as	described	in	Bolla	et	al.	 [176].	Purification	of	Omp50	 was	 performed	 as	 described	 in	 the	 Material	 and	 Methods	 section	 of	Chapter	2	(Paragraph	2.3.1).		Omp50	 from	 C.	 jejuni	 11168	 was	 produced	 in	 collaboration	 with	 Prof.	 Panos	Sultanos	 and	 Dr.	 Mahdavi	 from	 the	 University	 of	 Nottingham.	 C.	 jejuni	 11168	cultures	were	also	prepared	as	described	in	Bolla	et	al.	[176].				
3.2.2	Omp50	cloning	
	The	Omp50	gene	from	C.	jejuni	85H,	codon	optimized	for	E.	coli,	was	synthesized	by	Eurofins	(Germany).	The	gene	was	cloned	 in	two	different	vectors	carrying	a	TamA	signal	peptide	and	a	His6-tag,	either	at	the	C-terminus	(pTamACterHisTEV)	or	at	the	N-terminus	(pTamAHisTEV),	with	a	Tobacco	etch	virus	(TEV)	protease	site	placed	between	the	His6-tag	and	the	gene.	Both	plasmids	carried	an	ampicillin	resistance	gene	(cloning	was	performed	by	Dr.	Gregor	Wallat).			In	order	to	purify	Omp50	from	inclusion	bodies	(IB),	Omp50	gene	was	cloned	into	a	pTacHisTev	vector.	This	vector	carries	a	N-terminus	His6-tag	followed	by	a	TEV	
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recognition	site,	however,	unlike	the	pTamA	vectors,	pTacHisTev	lacks	the	signal	peptide.	 Both	 Omp50	 gene	 and	 vector	 were	 digested	 using	 NcoI	 and	 HindIII	restriction	 enzymes	 (both	Promega)	 at	 37	 °C	 for	 3	 hours.	 Subsequently,	 2	 μl	 of	alkaline	 phosphatase	 (Promega)	was	 added	 to	 the	 vector	 and	 incubated	 for	 an	additional	30	minutes	at	37	°C.	The	Omp50	gene	and	the	pTacHisTev	vector	were	then	 ligated	 at	 room	 temperature	 (RT),	 overnight	 using	 a	 T4	 ligase	 (Promega).	The	 ligation	mixture	 was	 later	 used	 to	 transform	 DH5α	 cells.	 The	 transformed	cells	 were	 plated	 onto	 LB	 agar	 plates	 and	 supplemented	 with	 100	 μg/ml	 of	ampicillin.	 Colonies	 were	 picked	 and	 grown	 in	 10	 ml	 LB	 media	 supplemented	with	100	μg/ml	of	ampicillin	at	37	°C	and	shaken	at	200	rpm	overnight.	Cells	were	mini-prepped	using	the	commercial	kit	QIAprep®	Spin	Miniprep	Kit	(Qiagen)	and	the	plasmid	sent	for	sequencing	(GATC	Biotech).		
3.2.3	Single	base	site-directed	mutagenesis	
	Single	base	site-directed	mutagenesis	was	performed	to	substitute	the	tyrosine	in	position	348	with	a	phenylalanine	using	 the	method	described	by	Dr.	 Liu	 [209]	(Figure	3.1).	 Polymerase	 chain	 reaction	 (PCR)	was	 carried	 out	 using	 a	Pfu	 DNA	polymerase	 (Promega)	 and	a	 two	 stage	 amplification	 cycle	was	 chosen.	 Specific	primers	 were	 designed	 with	 overlapping	 and	 non-overlapping	 regions	 (Table	3.1).	The	PCR	product	was	then	incubated	with	2	μl	of	DpnI	(Promega)	(1U/μl)	at	37°	 C	 for	 4	 hours.	 This	 step	 ensured	 the	 total	 degradation	 of	 the	 methylated	(parental)	DNA.	To	check	the	amplification	efficiency,	a	small	aliquot	(5	μl)	of	the	digested	sample	was	analyzed	by	agarose	gel	electrophoresis.	Consecutively,	50	μl	
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DH5α	E.	coli	cells	were	transformed	with	100	ng	of	PCR	product,	plated	onto	LB	agar	plates	and	supplemented	with	100	μg/ml	of	ampicillin.	Colonies	were	picked	and	grown	at	37	°C,	200	rpm	overnight	in	10	ml	LB	media	supplemented	with	100	μg/ml	of	ampicillin.	Then	cells	were	subsequently	spun	down	at	4,000x	g	for	10	minutes	at	4	°C	and	mini-prepped	using	a	QIAprep®	Spin	Miniprep	Kit	(Qiagen).	To	 confirm	 the	 presence	 of	 the	mutation,	 the	 plasmid	was	 sent	 for	 sequencing	(GATC	Biotech).				
	
Figure	 3.1:	 Schematic	 representation	 of	 primers	 used	 for	 site-directed	
mutagenesis.	Figure	was	adapted	from	[209].	
			
Table	3.1.	Primers	used	to	generate	Omp50	Y348F.	
					
5’	
5’	
3’	
3’	 Non	overlapping	region	
Non	overlapping	region	
Overlapping	region	
5'TCTTTGGGCTTCAGTCATGGGAACAATAATCAACTGTCCAGCACGCTG3’	
3’AAACCGTGGTTAAAGTTGATGAAATAGAGAAACCCGAAGTCAGTACCC5’		
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3.2.4	Small-scale	expression	
	For	 small-scale	 expression,	 pTamAHisTev-Omp50	 and	 pTamAHisCter-Omp50	were	transformed	in	different	cell	lines	(BL21(DE3),	BL21(DE3)Omp8,	C43(DE3),	C41(DE3)).	1	μl	of	DNA	was	incubated	with	50	μl	of	competent	cells	and	left	for	30	minutes	 on	 ice,	 followed	 by	 1	 min	 at	 42	 °C	 for	 heat	 shock.	 Cells	 were	 then	incubated	with	400	μl	of	LB	media	and	left	growing	for	1	hour	at	37	°C,	shaking	at	200	rpm.	Consecutively,	cells	were	plated	onto	LB-agar	plates	supplemented	with	100	μg	ml-1	ampicillin	and	left	at	37	°C	overnight.	Next	day,	a	colony	for	each	cell	line	was	picked	and	inoculated	in	10	ml	LB	supplemented	with	ampicillin	100	μg	ml-1	and	was	grown	overnight	at	37	°C	and	200	rpm.	100	μl	of	this	starter	culture	was	 then	 used	 to	 inoculate	 10	ml	 of	 fresh	media	 (LB,	 TB	 and	 TPB	media	were	tried	for	small-scale	expression	trails)	supplemented	with	100	μg	ml-1	ampicillin.	This	was	 incubated	at	37	°C	and	shaken	at	200	rpm	until	O.D600	reached	0.6-0.7	and	subsequently	induced	with	0.4	mM	of	isopropyl	β-D-1-thiogalactopyranoside	(IPTG).	 After	 induction,	 cells	 were	 left	 growing	 either	 for	 3	 hours	 at	 37	 °C,	 or	overnight	at	either	16	°C	or	25	°C.	Samples	were	taken	and	run	on	an	SDS-PAGE	to	check	the	expression	level.	The	gel	was	stained	with	Coomassie	blue	stain.		
3.2.5	Large-scale	expression			The	pTamAHisTev-Omp50	construct,	transformed	in	C43(DE3)	cell	line,	was	used	for	large-scale	expression.	Initially,	a	12	L	of	TPB	media	supplemented	with	100	μgml-1	of	ampicillin	was	inoculated	with	10	ml	of	start	culture	and	left	grown	at	
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37	°C	 for	3	hours	after	 induction.	Due	 to	 the	 low	yield	obtained	 for	 the	purified	Omp50,	auto-induction	media	for	large-scale	was	attempted.			The	starter	culture	was	prepared	by	inoculating	100	ml	of	LB,	containing	100	μg	ml-1	of	ampicillin	and	1%	(w/v)	of	glucose	(Sigma),	with	one	colony	of	plasmid-transformed	C43(DE3).	After	overnight	growth	at	37	°C,	10	ml	of	the	start	culture	was	 used	 to	 inoculate	 12x400	 ml	 of	 ZYP-5052	 media	 supplemented	 with	ampicillin.	 Adequate	 aeration	 is	 essential	 to	 reach	 an	 optimum	 level	 of	 protein	expression,	therefore	no	more	than	400	ml	of	media	was	used	in	2	L	baffled	flasks.	The	 culture	was	 incubated	 at	 20	 °C	 and	 shaken	 at	 250	 rpm	 for	 48	 hours.	 Cells	were	 harvested	 by	 centrifugation	 at	 6,000x	 g	 at	 4	 °C	 for	 10	minutes	 (rotor	 JLA	8.100,	Beckman).	
3.2.6	Purification	of	Omp50	Wt	and	Omp50	Y348F	
	To	purify	Omp50	Wt	and	Omp50	Y348F,	100	g	of	cell	paste	was	resuspended	in	400	 ml	 of	 lysing	 buffer	 and	 lysed	 with	 two	 passes	 at	 30	 kpsi	 through	 a	 high-pressure	cell	disruption	system	(Constant	System	Ltd).	Debris	were	removed	by	spinning	down	the	lysed	cells	at	15,000x	g	at	4	°C	for	15	minutes	(rotor	JA	25.50,	Beckman).	Total	membranes	were	recovered	by	ultracentrifugation	at	100,000	x	g,	4	°C	for	1	hour	(rotor	Ti5.2,	Beckman).	The	pellet	was	homogenized	in	50	mM	Na3PO4	pH	8,	250	mM	NaCl,	10	mM	β-mercaptoethanol	(BME)	and	7	%	Octyl-POE.	Solubilized	 membrane	 were	 left	 stirring	 overnight	 at	 4	 °C.	 The	 following	 day,	insoluble	material	was	removed	by	ultracentrifugation	at	100,000	x	g	and	4°C	for	1	hour.	The	supernatant	(approximately	200	ml)	was	then	incubated	with	5	ml	of	
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nickel	 nitriloacetic	 acid	 (Ni-NTA)	 resin	 (Qiagen)	 at	 4°C,	 stirring	 for	 1	 hour.	 The	resin	was	 previously	washed	 twice	with	water	 to	 remove	 the	 ethanol	 used	 for	storage,	 and	 ultimately	 equilibrated	 with	 the	 buffer	 used	 for	 the	 protein	extraction.	 After	 2	 hours,	 the	 sample	 was	 loaded	 onto	 a	 100	 ml	 gravity	 flow	column	(BIO-RAD)	and	the	flow	through	collected.	The	resin	was	washed	with	10	CV	 of	 washing	 buffer	 supplemented	 with	 5	 mM	 BME	 and	 eluted	 with	 2	 CV	 of	elution	 buffer	 also	 supplemented	 with	 5	 mM	 BME	 (Appendix	 A.2).	 The	 eluted	protein	was	then	dialyzed	against	500	ml	of	dialysis	buffer	(Appendix	A.2)	at	4°C	for	30	minutes	to	reduce	the	concentration	of	imidazole.	A	snakeskin	membrane	(Thermo	scientific)	with	a	10	kDa	cut	off	was	used	during	dialysis.	Subsequently,	His-tagged	TEV	 protease	was	 added	 to	 the	 protein	 to	 a	 final	 ratio	 of	 1:10	TEV:	protein.	The	protein	was	left	in	dialysis	overnight	at	4°C.	The	next	day,	the	sample	was	 filtered	 through	 a	 0.45	 μm	 filter	 and	 applied	 to	 a	 5	 ml	 His-trap	 column	(Qiagen)	using	a	peristaltic	pump.	At	this	point	the	cleaved	protein	flowed	though	the	column	while	the	His-tagged	TEV	remained	bound.		The	cleaved	protein	was	then	concentrated	to	5	ml,	spun	down	at	14,000	rpm	for	15	minutes	(centrifuge	5417R,	 Eppendorf),	 and	 loaded	 onto	 a	 16/60	 200	 pg	 superdex	 column	 (GE	healthcare)	 that	was	equilibrated	with	2	CV	of	10	mM	Tris-HCl	pH	8.0,	150	mM	NaCl	 and	 either	 0.45%	 C8E4,	 1%	 N,N-Dimethyldodecylamine	 N-oxide	 (LDAO)	(Sigma),	1%	n-Octyl-β-D-Glucopyranoside	(OG)	(Anatrace)	or	1%	n-Dodecyl	β-D-maltoside	(DDM)	(Anatrace).		The	protein	was	then	concentrated	to	10	mg	ml-1.				
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3.2.7	Omp50	inclusion	bodies	(IB)	purification		C43(DE3)	 cell	 line	were	 transformed	with	 the	pTacHisTev	plasmid	 carrying	 the	Omp50	gene.		Cells	were	plated	onto	LB-agar	plates	and	grown	overnight	at	3°C.	One	colony	was	picked	and	used	to	inoculate	20	ml	of	LB.	The	starter	culture	was	left	 overnight	 at	 37°C	 and	 200	 rpm.	 Subsequently,	 1	 x	 2	 L	 of	 LB	 media,	supplemented	with	100	μg	ml-1	of	ampicillin,	was	inoculated	with	10	ml	of	start	culture	and	left	growing	at	37°C	until	O.D.600	reached	0.6.	Cells	were	induced	with	0.4	 mM	 of	 IPTG	 and	 left	 overnight	 at	 25°C	 and	 200	 rpm.	 Induced	 cells	 were	harvested	at	6000x	g,	4°C	for	15	minutes.	The	recovered	pellet	was	resuspended	in	 50	 ml	 lysis	 buffer	 and	 broken	 with	 two	 passes	 through	 a	 cell	 disrupter.	Inclusion	bodies	were	 then	recovered	by	centrifugation	at	20,000	rpm,	20°C	 for	20	minutes	 (rotor	25.50,	Beckman),	and	 the	pellet	 resuspended	 in	 the	 IB	buffer	supplemented	with	 1%	X100-Triton	 and	 left	 rocking	 at	RT	 for	 15	minutes.	 The	suspension	was	 then	spun	down	again	at	20,000	rpm,	20°C	 for	20	minutes.	The	recovered	pellet	was	washed	 twice	with	 IB	buffer	 (no	Triton	X-100)	 (Appendix	A.2)	 and	 then	 recovered	 by	 centrifugation	 at	 20,000	 rpm,	 20°C	 for	 20	minutes.	Finally	the	protein	was	extracted	resuspending	the	IB	in	IB	buffer	supplemented	with	8	M	Urea	pH	8	and	 left	 rocking	at	RT	overnight.	The	 suspension	was	 then	clarified	by	centrifugation	at	20,000	rpm,	at	20°C	for	20	minutes.	The	supernatant	was	 diluted	 10-fold	 in	 refolding	 buffer,	 supplemented	with	 1%	 of	 either	 LDAO,	Octyl-POE,	 or	 Elugent	whilst	 stirring	 at	 RT	 for	 three	 days.	 The	 suspension	was	then	 clarified	 by	 centrifugation	 at	 20,000	 rpm,	 at	 20°C	 for	 20	 minutes	 and	checked	by	SDS-PAGE.		
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3.2.8	Crystallization	
	Initial	 trials	 were	 done	 using	 several	 commercial	 screens.	 The	 screens	 were	dispensed	 into	 a	96-well	 sitting	drop	plate	 (Intelli-Plate®,	ARI)	using	 a	Gryphon	robot,	at	a	protein:reservoir	ratio	of	1:1	and	1:2.	First	hits	appeared	within	three-four	weeks.	When	necessary,	crystallisations	conditions	were	manually	optimized	by	the	hanging-drop	vapor	diffusion	technique.	In	order	to	improve	the	quality	of	the	crystals,	commercial	additive	screens	were	explored,	and	were	also	dispensed	using	the	Gryphon	robot.			
In	situ	proteolysis	of	Omp50	was	also	attempted	using	different	proteases.	Stock	solution	 at	 1	 mg/ml	 of	 Subtilis	 A,	 Trypsin,	 Chemotrypsin	 and	 Papain	 were	prepared	in	specific	buffers	(listed	in	Appendix	A.2)	flash	frozen	in	liquid	nitrogen	and	stored	at	–	20°C.	Omp50,	at	a	concentration	of	10	mg/ml,	was	incubated	at	RT	for	 an	 hour	 with	 different	 proteases	 at	 a	 final	 ratio	 of	 either	 1:10	 or	 1:100	protein:protease.	 The	 reaction	 was	 stopped	 by	 adding	 LDS	 loading	 buffer	(Promega).	Omp50	proteolytic	products	were	checked	by	SDS-PAGE.		
	
3.2.9	Lipid	cubic	phase	(LCP)	
	To	 set	up	LCP	plate	we	used	 the	method	described	by	Caffrey	 and	Porter[210].	Briefly,	 Omp50,	 at	 a	 concentration	 of	 15	 mg/ml,	 was	 mixed	 with	 monoolein	(Molecular	Dimension)	at	a	final	ratio	of	2:3	protein:monoolein.	The	glass	syringe	and	the	tip	used	to	mix	the	protein	and	the	monoolein	was	quickly	warmed	up	at	42°C	 on	 the	 top	 of	 a	 heating	 block.	 This	 prevented	 the	 monoolein	 solidifying	
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during	the	mixing.	Care	was	taken	to	avoid	bubbles	during	this	process.	Once	the	mixing	was	completed,	the	syringe	was	attached	to	the	Gryphon	robot.	Previously,	several	LCP	glass	plates	were	prepared	as	 follows.	The	plates	were	coated	with	Rainex	 and	 left	 to	 dry	 for	 a	 few	minutes.	 Consecutively,	 the	 plates	were	 rinsed	with	 milliQ	 water	 and	 dried	 with	 a	 tissue.	 Once	 dried,	 a	 96-well	 spacer	 was	stacked	on	 the	 top	of	 the	each	of	 the	glass	plates.	The	distance	between	the	 left	edge	of	the	plate	and	the	spacer	was	roughly	0.5	cm,	while	the	distance	between	the	 right	 edge	 and	 spacer	 was	 roughly	 1.5	 cm.	 The	 plates	 were	 placed	 on	 the	metal	base	of	the	Gryphon	robot.	Several	commercial	screens	were	dispensed.	For	each	 well,	 the	 Gryphon	 dispensed	 800	 nl	 of	 reservoir	 and	 50	 nl	 of	 the	protein/monoolein	 mixture.	 Once	 the	 process	 was	 completed,	 the	 plates	 were	removed	from	the	Gryphon	and	covered	with	a	glass	coverslip	and	imaged	using	a	Ministrel	device	(Rigaku).		
3.2.10	Single	channel	conductance	analysis	of	Omp50	
	Details	 of	 the	 protocol,	 setup	 and	 software	 used	 to	 perform	 the	measurements	were	 essentially	 the	 same	 as	 described	 in	 the	Material	 and	Methods	 section	 of	Chapter	2	(paragraph	2.3.5).			Single	 channel	 measurements	 of	 recombinantly	 expressed	 Omp50	 were	 taken	from	1	M	KCl,	10	mM	MES	pH	6.	Omp50	was	added	to	the	cis	side	of	the	cuvette	at	a	final	concentration	of	2	ng	ml-1.			
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3.2.11	Western	blot	with	antibodies	anti	phosphorylated	tyrosine	
	Omp50,	 Wzc	 (positive	 control)	 and	 Omp36	 (negative	 control),	 all	 at	 a	 final	concentration	of	1	mg/ml	were	run	on	a	SDS-PAGE	gel.	Omp50	and	Y348F	Omp50	were	incubated	with	10	mM	MgCl2	and	1	mM	ATP	for	1	hour	at	RT.	A	pre-stained	ladder	 (Novex®	 Sharp	 Pre-stained,	 Life	 Technology)	was	 used	 for	 the	 standard.	The	 gel	 was	 run	 for	 35	 minutes	 at	 200	 V	 and	 subsequently	 transferred	 for	blotting.	 Six	 pieces	 of	 blotting	 paper	 were	 cut	 and	 soaked	 in	 different	 buffers	(Appendix	A.2).	One	piece	of	paper	was	soaked	in	anode	buffer	1,	two	pieces	were	soaked	in	anode	buffer	2	and	the	last	three	pieces	were	soaked	in	cathode	buffer.	A	piece	of	polyvinylidene	difluoride	(PVDF)	membrane	(Sigma)	(same	size	of	the	gel)	 was	 pre-soaked	 in	 50	 ml	 of	 methanol	 (Sigma).	 The	 blotting	 stack	 was	assembled	 by	 the	 placement	 of	 the	 two	 pieces	 of	 blotting	 paper	 soaked	 in	 the	anode	buffer	1	at	the	bottom	of	the	stack,	followed	by	the	anode	buffer	2	soaked	paper,	 the	 PDV	 membrane,	 the	 gel	 and	 finally	 the	 three	 papers	 soaked	 in	 the	cathode	buffer.	The	 transfer	was	performed	using	a	 semi-dry	 transfer	 cell	 (Bio-RAD),	applying	25	V	for	1	hour.	A	blocking	solution	was	made	by	dissolving	2.5	g	of	milk	 powder	 in	 50	ml	 PBS.	 The	membrane	was	 placed	 inside	 a	 50	ml	 falcon	tube	filled	with	the	blocking	solution	and	left	rolling	for	1	hour	at	4°C.	Then	the	blocking	solution	was	poured	off	and	replaced	with	10	ml	PBS	supplemented	with	a	 1:1000	 dilution	 of	 monoclonal	 anti-phosphotyrosine-peroxidase	 antibody	(Sigma-Aldrich)	and	left	rolling	for	1	hour	at	4°C.	The	antibody	stock	solution	was	prepared	 according	 to	 manufacturer’s	 instructions.	 The	 membrane	 was	 then	washed	 3	 times	with	 40	ml	 of	 PBS	 to	 remove	 excess	 antibody.	 To	 develop	 the	western	blot,	equal	amounts	(1	ml)	of	detection	reagents	(SuperSignal®	West	Pico	
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Chemiluminescent	 substrate,	 Thermo	 Scientific)	were	 applied	 to	 the	membrane	prior	to	imaging	with	a	ChemiDoc	imager	(Bio-RAD).	
	
3.2.12	Radioactive-thin	layer	chromatography	(TLC)		
	Radioactive	 thin-layer	 chromatography	 (TLC)	 was	 performed	 in	 order	 to	investigate	 the	 kinase	 activity	 of	 Omp50	 and	 its	 mutated	 form,	Omp50Y348F.	Apyrase	and	hexokinase	(both	Sigma)	reaction	products	were	used	to	 locate	 the	 radioactive	 spots	 corresponding	 to	 adenosine	 monophosphate	(AMP)	and	adenosine	diphosphate	 (ADP),	 respectively.	Different	 reactions	were	prepared	as	listed	in	Table	3.2.	Each	reaction	(20	μl)	was	incubated	with	20	μl	of	an	adenosine	 triphosphate	 (ATP)	mixture	containing	0.3	μCi	of	[α-32P]	ATP	(hot	ATP)	and	0.1	mM	of	non-radioactive	ATP	(cold	ATP)	(both	Sigma)	 for	1	hour	at	RT.	 A	 TLC	 polyethylenimine	 (PEI)	 cellulose	 membrane	 (Macherey-Nagel)	 was	prewashed	with	milliQ	water	and	left	to	dry	on	the	bench.	Following	prewash,	1	μl	of	 each	 reaction	was	 then	 spotted	onto	 the	membrane.	 In	 order	 to	 obtain	well-defined	spots,	each	spot	was	applied	at	0.4	cm	interval,	and	always	approximately	3	cm	above	the	bottom	of	the	membrane.	Each	reaction	was	spotted	in	duplicate.	The	membrane	was	run	in	0.9	M	Guanadine-HCl	in	a	TLC	glass	chamber	for	1	hour	at	 room	 temperature.	 The	membrane	was	 dried	 on	 the	 bench,	wrapped	 in	 film	and	exposed	to	an	imaging	plate	for	15	minutes.	The	plate	was	phosphor	imaging	using	a	Typhoon	FLA	7000	laser	scanner	(GE	Healthcare).			
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Table	3.2.	List	of	reagents	used	for	the	radioactive	TLC	
	
	(*)	Apyrase+	ATP->	AMP+2Pi	(**)	Hexokinase+ATP+glucose->Glucose-6-phosphate+	ADP	
	
	
	
	
	
	
	
	
	
	
	
	
	
 (*) AMP 
Standard 
 
(**) ADP 
Standard 
ATP 
Standard 
Omp50 
WT 
Omp50
Mutant 
10mM Tris pH8	 ✓	 ✓	 ✓	 ✓	 ✓	
10 mM MgCl2	 ✓	 ✓	 ✓	 ✓	 ✓	
150 mM NaCl	 ✓	 ✓	 ✓	 ✓	 ✓	
0.45% C8E4	 	 	 	 ✓	 ✓	
2 mM D-glucose 	 ✓	 	 	 	
1U/µl Apyrase ✓	 	 	 	 	
1U/µl Hexokinase 	 ✓	 	 	 	
4,6,8,or 10 µM Omp50 	 	 	 ✓	 	
8 or 10 µM 
Omp50Y348F 
	 	 	 	 ✓	
H20 up to 20 µl ✓	 ✓	 ✓	 ✓	 ✓ 
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3.3.Results	
	
3.3.1	Omp50	purification	from	the	native	C.	jejuni	85H	strain		The	purification	protocol	 from	Bolla	et	al	 allowed	 the	 extraction	of	both	MOMP	and	Omp50	porins	from	the	outer-membrane	of	C.	jejuni	(Chapter	2,	Figure	2.3).	However,	the	level	of	the	expression	and	so	the	final	yield	of	purified	Omp50	was	very	 low	 and	 not	 useful	 for	 crystallographic	 studies.	 Therefore,	 no	 further	experiments	were	 carried	out	using	Omp50	natively	 expressed	 in	C.	 jejuni	85	H	strain.		
3.3.2	Omp50	recombinant	expression	and	purification		Omp50	was	overexpressed	with	either	an	N-terminus	or	a	C-terminus	His6-tag	in	several	cell	lines.	The	level	of	expression	of	Omp50	with	the	C-terminus	His6-tag	was	 low	 and	 therefore	 no	 further	 experiments	 were	 carried	 out	 with	 this	construct.	N-terminus	tagged	Omp50	showed	higher	levels	of	expression	and	was	consequently	 used	 for	 small	 and	 large-scale	 purification.	 Omp50	 was	overexpressed	in	C43(DE3)	cell	line	using	TBP	media	and	inducted	at	high	OD600	at	37	°C	for	3	hours.	Omp50	was	extracted	using	Octyl-POE,	isolated	using	nickel	resin,	TEV	cleaved	and	further	purified	using	size	exclusion	chromatography.	The	SEC	 profile	 showed	 a	 single	 peak,	whose	 fractions	were	 analyzed	 by	 SDS-PAGE	and	identified	as	Omp50	by	MS;	(Figure	3.2	A-B)	the	purified	peak	yielded	0.2	mg	L-1	of	protein	culture.	In	order	to	improve	the	final	yield,	Omp50	was	over-expressed	in	C43(DE3)	using	
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auto-induction	media	and	BME	was	added	during	all	the	steps	of	the	purification.	The	 gel	 filtration	 profile	 showed	 a	 single	 peak.	 Fractions	 of	 the	 peak	 were	analyzed	by	SDS-PAGE	and	protein	identity	confirmed	by	MS.	The	protein	showed	degradation	during	 the	purification	process	 (Figure	3.2	C-D).	Final	protein	yield	was	0.6	mg	L-1	of	protein	culture.		Refolding	 was	 also	 attempted	 to	 increase	 the	 final	 protein	 yield.	 Omp50	 was	extracted	 from	 IB	 using	 urea.	 Refolding	 was	 carried	 out	 by	 diluting	 the	suspension	containing	 the	unfolded	Omp50	 in	refolding	buffer	containing	either	Elugent,	 LDAO	 or	 Octly-POE.	 Unfortunately,	 none	 of	 the	 buffers	 used	 led	 to	 a	refolded	protein.	Omp50	precipitated	during	 the	 refolding	process	as	 judged	by	SDS-PAGE.			
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Figure	3.2:	Omp50	purification:	 (A)	SEC	profile	of	Omp50	expressed	in	TBP	media.	A	10/300	S75	GE	column	was	used	for	the	SEC.	(B)	SDS-PAGE	of	chosen	fractions	from	the	SEC	 peak.	M	 is	 the	 ladder.	 Bands	 at	 50	 kDa	 and	 at	 110	 kDa	 are	Omp50	monomer	 and	dimer,	 respectively	 as	 confirmed	 by	mass-spec.	 (C)	 SEC	 profile	 of	 Omp50	 expressed	 in	auto-induction	media.	A	16/60	S200	GE	column	was	used	for	the	SEC.	(D)	The	SDS-PAGE	of	chosen	fractions	from	the	SEC	peak.	M	is	the	ladder,	bands	at	50	kDa	are	Omp50,	while,	the	lower	MW	bands	are	products	of	degradation	of	Omp50	as	confirmed	by	mass-spec.		
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3.3.3	Omp50	crystallization		Crystallization	of	Omp50	was	carried	out	against	several	commercial	screenings.	Most	of	 the	drops	were	clear	or	were	displaying	 large	amounts	of	precipitation.	However,	small	cubic	crystals	appeared	after	approximately	4	weeks	(Figure	3.3).	The	crystals	were	confirmed	to	be	protein	crystals	due	 to	absorbance	under	UV	light.	When	 tested,	however,	 they	showed	no	diffraction.	Attempts	 to	reproduce	and	 optimized	 the	 crystals	 were	 unsuccessful.	 Additive	 screening	 also	 did	 not	improve	the	reproducibility	of	the	crystals.			
	
Figure	 3.3:	 Crystallisation	 of	 Omp50.	 Crystals	 grown	 using	 the	 sitting	 drop	 vapor	technique.	(A)	Under	visible	light	(B)	Under	UV	light		
	Omp50	was	 subject	 to	 limited	 proteolysis	 using	 several	 proteases	 at	 a	 ratio	 of	1:10	or	1:100	v/v.	The	proteolytic	products	were	analyzed	by	SDS-PAGE	in	order	to	 identify	 the	most	promising	degradation	pattern	 (Figure	3.4).	The	proteolitic	products	 obtained	 from	 the	 digestion	 with	 trypsin	 at	 a	 ratio	 of	 1:10	 v/v	 were	found	to	be	the	largest	and	the	most	stable	and	therefore	used	for	crystallization	
50μm	 50μm	A.	 B.	
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trials.	 Unfortunately,	 the	 use	 of	 limited	 proteolysis	 did	 not	 improve	 the	crystallization	of	Omp50.			
	
Figure	 3.4:	 SDS	 gel	 of	 Omp50	 proteolitic	 products.	 SDS	 gel	 of	 the	Omp50	products	obtained	by	limited	proteolysis	using	subtilisA,	trypsin,	chemotrypsin	and	papain.			
3.3.4	Lipid	cubic	phase	(LCP)	
	In	 an	 attempt	 to	 get	 high	 quality	 crystals,	 the	 LCP	 technique	 was	 used	 as	 an	alternative	 to	 the	 vapor	 diffusion	 technique.	 Omp50	 was	 mixed	 with	 the	 lipid	monooline,	 and	 the	 mixture	 was	 used	 to	 set	 up	 crystal	 trials	 against	 several	commercial	 screenings.	 	 In	 this	 case,	 however,	 the	 LCP	 technique	 was	unsuccessful	and	no	crystals	were	detected.			
Co
nt
ro
l	
1:
10
		s
ub
.l
isA
	
1:
10
0	
	su
b.
lis
A	
1:
10
		T
ry
ps
in
	
1:
10
	0
	T
ry
ps
in
	
1:
10
		C
he
m
oT
ry
ps
in
α	
1:
10
0	
	C
he
m
oT
ry
ps
in
α	
1:
10
		P
ap
ai
n	
1:
10
	0
	P
ap
ai
n	
50-	
25-	
75-	
37-	
110-	
kDa	
Chapter	3:	Omp50	from	Campylobacter	jejuni	
	 91	
3.3.5	Single	channel	conductance	measurements	of	Omp50	
	Omp50	conductivity	was	assessed	by	single	channel	measurements	in	1	M	KCl,	10	mM	 MES	 pH	 6.	 Omp50	 inserted	 was	 into	 the	 bilayer	 as	 a	 monomer	 with	 a	conductance	of	53±0.2	pS.	The	insertion	of	the	protein	was	difficult	to	achieve	and	the	 channel	 became	 unstable	when	 a	 voltage	 higher	 than	 100	mV	was	 applied.	The	 channel	 showed	 a	 high	 flickering	 rate,	 which	 is	 clear	 from	 the	 ion-current	trace	(Figure.	3.5).			
	 	
Figure	 3.5:	 Single	 channel	 measurement.	 (A)	 I-V	 profile	 of	 Omp50.	 (B)	 Ion-current	trace	of	Omp50.										
A.	 B.	
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3.3.6	Western	blot	with	antibodies	anti	phosphorylated	tyrosine		Omp50	 auto-phosphorylation	 activity	 was	 assayed	 by	 western	 blot	 using	 an	antibody	against	phosphorylated	 tyrosine.	Wzc-	an	E.	coli	BY-kinase	 involved	 in	the	capsule	biosynthesis-	was	used	as	a	positive	control,	while	Omp36	–	a	general	porin	 from	Enterobacter	aerogenes	 –	was	 used	 as	 negative	 control.	 Omp50	was	analyzed	before	and	after	incubation	with	MgCl2	and	ATP.	In	both	cases	we	could	not	detect	any	phosphorylated	tyrosine	(Fig.	3.6).			
	
Figure	3.6:	WB	against	phosphorylated	tyrosine.	(A)	SDS	gel	of	the	sample	tested	for	tyrosine	 phosphorylation.	 (B)	 WB	 with	 ab	 against	 phosphorylated	 tyrosine.	 Control+	(Wzc	from	E.	coli),	Omp50,	Omp50	incubated	with	MgCl2	and	ATP,	control-(Omp36	from	
E.	aerogenes).						
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In	 collaboration	 with	 Prof.	 Panos	 Sultanos	 and	 Dr.	 Mahdavi	 (University	 of	Nottingham),	 we	 were	 able	 to	 purify	 Omp50	 from	 the	 native	 C.	 jejuni	 11168	strain,	the	same	strain	used	for	the	experiments	performed	by	Corcionivoschi	et	
al.	We	repeated	 the	WB	with	antibodies	anti	phosphorylated	 tyrosine,	however,	also	in	this	case,	we	did	not	detect	any	phosphorylation	(Figure	3.7).			
	
Figure	3.7:	WB	against	phosphorylated	tyrosine.	(A)	SDS	gel	of	the	sample	tested	for	tyrosine	 phosphorylation.	 (B)	 WB	 with	 ab	 against	 phosphorylated	 tyrosine.	 Control+	(Wzc	from	E.	coli),	Omp50	from	C.	jejuni	11168,	Omp50	85H.		
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3.3.7	Radioactive-thin	layer	chromatography	(TLC)		
	Radioactive	 TLC	 was	 used	 to	 determine	 if	 Omp50	 was	 able	 to	 hydrolyze	 ATP.	Different	concentrations	of	Omp50	were	incubated	with	a	mixture	of	hot	and	cold	ATP	and	ran	on	a	TLC	membrane.	To	localize	the	radioactive	spots	corresponding	to	AMP,	ADP	and	ATP,	standards	were	also	run.	The	spots	corresponding	to	 the	reaction	products	of	Omp50	showed	that	the	ATP	was	not	efficiently	hydrolyzed.	However,	 we	 noticed	 some	 background	 that	 we	 hypothesized	 could	 have	 been	due	to	a	contaminant	and	not	 from	Omp50	activity.	We	therefore	decided	to	re-run	the	experiment	in	the	presence	of	Omp50Y348F	as	a	negative	control,	for	this	mutant,	a	similar	background	was	observed	as	in	the	native	protein	(Figure	3.8).		
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Figure	 3.8:	 Radioactive	 TLC	 of	 Omp50	 and	 Omp50	 Y348F.	 (A)	 Radioactive	 spots	corresponding	 (from	 the	 left)	 to	AMP,	ADP,	ATP	 and	products	 of	 (4,6,8,10	μM)	Omp50	activity.	 (B)	 Radioactive	 spots	 corresponding	 (from	 the	 left)	 to	 AMP,	 ADP,	 ATP	 and	products	of	(8	and10	μM)	Omp50	Y348F	and	(8	and	10	μM)	Omp50	activity.							 			
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3.4	Discussion	
	
3.4.1	Purification	and	crystallization	of	Omp50		Expression	and	purification	of	Omp50	was	originally	attempted	using	the	native	
C.	 jejuni.	 Unfortunately,	 due	 to	 the	 low	 level	 of	 the	 expression,	 the	 amount	 of	protein	 purified	 was	 not	 sufficient	 to	 start	 crystallization	 trials.	 Since	
Campylobacter	are	 fastidious	 to	grow	under	 laboratory	conditions,	 the	option	of	growing	 a	 larger	 quantity	 of	 bacteria	was	 rejected	 and	 recombinant	 expression	was	attempted	instead.		Omp50	was	 recombinantly	 over-expressed	 in	 C43(DE3)	E.	coli	 cells	 using	 auto-induction	 media.	 The	 purified	 protein	 was	 used	 in	 crystallization	 trials	 and	crystals	were	obtained	within	a	month.	However	no	diffraction	was	detected.	To	date,	 our	 attempts	 to	 reproduce	 and	 improve	 the	 crystals	 using	 various	techniques	have	been	unsuccessful.			
3.4.2	Homology	predictions	
	Structural	homology	predictions	of	Omp50	were	generated	using	the	web	server	Phyre2[211]	(Figure	3.9).	Omp50	predictions	gave	high	confidence	(>96%)	based	on	 18-β-stranded	 porins	 (MOMP,	 Occk9,	 Occk8,	 OccaB3,	 Opdo)	 (Table	 3.3).	Interestingly,	 except	 from	 MOMP,	 all	 the	 porins	 used	 for	 the	 prediction	 are	specific	porins	[212],[213],[42].			
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Table	3.3.	Phyre2	Omp50	prediction	models.	
Model	 Residues	aligned	 Confidence	%	 Identity	%	
MOMP	
(C.	jejuni)	
52-469	 99.1	 16	
Occk9	
(P.aeruginosa)	
59-437	 98.3	 14	
Occk8	
(P.aeruginosa)	
62-462	 97.8	 12	
OccaB3	
(A.	baumanii)	
58-463	 97.7	 12	
Opdo	
(P.aeruginosa)	
62-437	 97.6	 10		 				
	
Figure	3.9:	3D	homology	model	of	Omp50.	Phyre2	homology	prediction	using	MOMP	from	C.	jejuni	as	a	model.		
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3.4.3	Pore	activity	of	Omp50		Single	channel	experiments	revealed	 that	Omp50	recombinantly	expressed	 in	E.	
coli	 exhibits	 a	 conductance	 of	 53±0.2	 pS.	 Previously,	 Bolla	 et	 al.	 measured	 the	conductivity	of	the	native	Omp50[203],	and	we	found	those	measurements	agree	with	ours.	Omp50	conductance	is	similar	to	the	conductance	of	the	specific	porins	from	P.	aeruginosa	Occk4	and	Occk6	(43±11pS	and	71±34pS,	respectively)[214].	Conversely,	 unlike	 the	Occk	porins,	which	 showed	anion	 selectivity,	Omp50	has	been	shown	to	be	cation-selective	[203].	
	
3.4.4	Omp50	putative	tyrosine	kinase	activity		It	was	the	publication	of	Corcionivoschi	et	al.[207],	that	 led	us	to	investigate	the	allegedly	kinase	activity	of	Omp50.	BY-kinases	are	typically	constituted	of	two	α-helices	 spanning	 the	 inner	 membrane	 with	 the	 catalytic	 domain	 facing	 the	cytoplasm	[215],[208],[216].	Omp50,	however,	has	been	predicted	to	be	a	barrel	of	18	β-sheets	located	in	the	outer-membrane,	hence	significantly	different	from	a	typical	BY-kinase	structure.	Moreover,	while	ATP	concentration	in	the	cytoplasm	ranges	from	1-3	mM	[217],	it	has	been	shown	to	be	absent	or	considerably	low	in	the	periplasmic	and	in	the	extra-cellular	space	[218].	It	is	a	question	as	to	where	the	ATP	for	the	phosphorylation	of	Omp50	and	its	substrates	would	come	from.					
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In	 our	 experiments,	 western	 blots	 against	 phosphorylated	 tyrosine	 failed	 to	detect	any	phosphorylation	in	Omp50.	When	we	repeated	the	western	blot	using	Omp50	 natively	 expressed	 in	 C.	 jejuni	 11168	 we	 could	 not	 detect	 any	phosphorylation	either.	We	 also	 attempted	 to	 determine	 if	Omp50	was	 able	 to	 hydrolyze	ATP	by	 using	radioactive	TLC.	The	TLC	results	suggested	that	Omp50	does	not	have	any	kinase	activity,	since	no	products	of	ATP	hydrolysis	were	spotted	on	the	TLC	membrane.	Although	 some	 background	 was	 noticed	 while	 analyzing	 the	 results,	 Omp50	Y348F	(predicted	to	be	inactive)	gave	a	similar	background.			Taking	into	consideration	our	results,	 the	predicted	structure	of	Omp50	and	the	inaccessibility	to	the	ATP	needed	for	the	phosphorylation	process,	we	think	that	Omp50	it	is	unlikely	to	be	a	BY-kinase.													
Chapter	3:	Omp50	from	Campylobacter	jejuni	
	 100	
3.5	Conclusion	and	future	work	
	We	have	shown	that	we	can	over-express	Omp50	using	a	recombinant	system	and	purify	 a	 suitable	 quantity	 of	 protein	 for	 crystal	 trials.	 Reproducible	 Omp50	crystallization,	 however,	 was	 hard	 to	 achieve.	 Future	 work	 will	 be	 to	 test	 a	broader	range	of	detergents	and	buffers	to	improve	the	crystallization	process.			We	 also	 have	 shown	 that	 Omp50	 recombinantly	 expressed	 in	 E.	 coli	 is	 able	 to	form	pores	when	inserted	in	a	lipid	bilayer,	and	displayed	the	same	conductivity	as	the	natively	expressed	porin.		While	analyzing	the	in	vitro	kinase	activity	of	Omp50	we	did	not	see	any	evidence	for	activity.	Therefore	our	results	are	in	disagreement	with	Corcionivoschi	[207]	studies.											
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4.1	Introduction	
	
4.1.1	Enterobacter	aerogenes	infections	and	antibiotic	resistance	
	
Enterobacter	 aerogens	 are	 facultative	 anaerobic	 and	 opportunistic	 bacteria	belonging	 to	 the	 family	 of	 Enterobacteriacea,	 frequently	 isolated	 from	 the	respiratory	 and	urinary	 system	of	hospitalized	patients	 [219],[220].	E.	aerogens	infections	have	been	associated	with	high	levels	of	morbidity	and	mortality	[221].	For	 example,	 in	 Nepal	 in	 1999,	 E.	 aerogens	 infections	 led	 to	 an	 outbreak	 of	septicemia	in	a	neonatal	intensive	care,	causing	the	death	of	12	new	borns	[222].		Moreover,	an	increased	number	of	E.	aerogenes	strains,	isolated	from	nosocomial	patients,	 have	 exhibited	 a	 multi-drugs	 resistance	 (MDR)	 phenotype.	 MDR	 E.	
aerogens	strains	have	been	identified	all	over	Europe	[220].	The	expression	of	an	extended-spectrum	 β-lactamase	 [223],	 TEM-24	 [224],	 chromosomal	cephalosporinase,	and	recently	acquired	carbapenemases	confer	resistance	to	β-lactams	 [225],	 carbapenems	 along	 with	 resistance	 to	 the	 first	 generation	cephalosporin	 [226],[227].	 In	France,	 a	pan-drug	 resistant	 clone	of	E.	aerogenes	(EA1509E)	 has	 been	 isolated	 from	 a	 nosocomial	 patient,	 that	 was	 found	 to	 be	resistant	 to	 all	 the	 clinical	 relevant	 antibiotics	 with	 the	 only	 exception	 of	gentamycin	[228].	Similarly	in	Belgium,	several	patients	(aged	from	7	to	85	years)	were	 infected	with	 a	 clone	of	MDR	E.	aerogenes	 susceptible	 only	 to	 gentamycin	and	imipenem	[229].			
Chapter	4:	Omp35	and	Omp36	from	Enterobacter	aerogenes	
	 104	
In	 general,	 MDR	 is	 a	 complex	 mechanism	 regulated	 at	 different	 levels.	 Several	genes,	including	MarA,	RamA,	SoxS	are	involved	in	regulation	of	MDR,	specifically,	by	 up-regulating	 the	 expression	 of	 efflux	 pumps	 and	 down-regulating	 the	expression	 of	 porins	 [230],[231].	 Mutations	 and	 overexpression	 of	 these	 genes	have	 been	 linked	 to	 a	 high	 level	 of	 antibiotic	 resistance	 [230].	 In	 particular,	 an	overexpression	 of	 MarA	 has	 led	 to	 a	 2-	 to	 16-	 fold	 increase	 in	 resistance	 to	carbapenems	and	fluoroquinolones	in	E.	aerogenes	ATCC	13048	strain	[230].		
4.1.2	Enterobacter	aerogenes	porins	
		Two	major	 general	porins	 are	 found	 in	E.	aerogenes,	Omp35	 (OmpF-like	porin)	and,	Omp36	(OmpC-like	porin)[232].	Omp35	is	a	trimeric	porin	usually	expressed	under	low	osmolarity	conditions.	Pore	activity	of	Omp35	has	been	confirmed	by	single	 channel	 measurements	 of	 conductivity	 and	 cation	 selectivity	 have	 been	reported;	 these	values	are	similar	 to	what	has	been	observed	 for	OmpF	 from	E.	
coli	(4.22	nS	measured	at	pH	7)	[232].	Omp36	is	a	trimeric	porin	(homologous	of	OmpC	 from	 E.	 coli	 and	 OmpK36	 from	 K.	 pneumonia)	 expressed	 under	 high	osmolarity	conditions	[233].		In	MDR	E.	aerogenes	 isolates,	 porin	 expression	was	observed	 to	be	 significantly	altered[234][235].	 In	 ertapenem-resistant	 isolates	 the	 expression	 of	 Omp35	 is	down	 regulated	and	eventually	 completely	 suppressed	 [236].	 In	 ertapenem	and	imipenem-resistant	 isolates,	 along	 with	 Omp35,	 Omp36	 expression	 is	 also	suppressed	 [235].	 In	 clinical	 isolates,	mutations	 of	 the	 L3	 in	 Omp36	 have	 been	
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associated	 with	 antibiotic	 resistance	 [233].	 Most	 strikingly	 substitution	 of	 a	glycine	to	an	aspartic	acid	in	position	112	has	been	shown	to	decrease	the	uptake	of	β-lactams	and	cephalosporin[11].		
4.1.3	Aims	
		Alterations	of	the	expression	level	and	mutations	at	the	level	of	the	constriction	zone	of	Omp35	and	Omp36	have	been	linked	to	an	increased	antibiotic	resistance	in	E.	aerogenes	isolates.			In	order	to	analyze	how	clinically	relevant	antibiotics	translocate	via	Omp35	and	Omp36,	 we	 aimed	 to	 structurally	 and	 functionally	 characterize	 both	 porins.	Firstly,	we	aimed	to	over-express	Omp35	and	Omp36	in	E.	coli,	to	purify	them	and	ultimately	 solve	 their	X-ray	 structure.	 In	 addition,	we	aimed	 to	use	 the	purified	porins	 to	 measure	 the	 rate	 of	 permeations	 of	 several	 classes	 of	 antibiotics	 by	using	liposome	swelling	assay.				The	 work	 of	 this	 chapter	 also	 aimed	 to	 have	 a	 better	 understanding	 of	permeation	 through	 the	 orthologues	 of	 Omp35	 and	 Omp36	 (OmpF	 and	 OmpC	from	 E.	 coli,	 OmpE35	 and	 OmpE36	 from	 E.	 cloacae	 and	 OmpK35	 and	 OmpK36	from	K.	pneumonia).	To	do	so	we	decided	to	perform	the	liposome	swelling	assay	with	OmpC	and	OmpF	and	to	compare	the	data	obtained	with	data	shared	by	our	collaborators.			
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4.2	Materials	and	methods	
	
4.2.1	Cloning	and	expression	
	Codon	 optimized	 genes	 encoding	 for	 Omp35	 (ATCC	 15038)	 and	 Omp36	 (ATCC	13048)	from	E.	aerogenes	were	ordered	from	DNA2.0	(California,	USA)	and	cloned	into	 a	 pTAMAHisTEV	 ampicillin-resistant	 vector.	 The	 vector	 and	 genes	 were	digested	with	NcoI	and	BamHI	restriction	enzymes	at	37°C	 for	 three	hours.	The	vector	was	then	treated	with	alkaline	phosphatase	(Promega)	for	an	additional	30	minutes	 at	 37°C.	 Omp35	 and	 Omp36	 genes	 and	 the	 vector	 were	 ligated	 at	 RT,	overnight	 using	 T4	 ligase	 (Promega).	 The	 ligation	 mixture	 was	 later	 used	 to	transform	 DH5α	 cells.	 The	 transformed	 cells	 were	 plated	 onto	 LB	 agar	 plates	supplemented	with	100	μg/ml	of	ampicillin.	Colonies	were	picked	and	grew	in	10	ml	 LB	 media	 supplemented	 with	 100	 μg/ml	 of	 ampicillin	 at	 37°C,	 200	 rpm	overnight.	 Cells	 were	 miniprepped	 using	 the	 commercial	 kit	 QIAprep®	 Spin	Miniprep	Kit	(Qiagen)	and	the	plasmid	sent	to	sequencing	(GATC	Biotech).			The	 Omp-constructs	 were	 transformed	 in	 porin-deficient	 E.	 coli	 BL21omp8-competent	cells.	For	the	overnight	culture,	250	ml	of	LB	culture	containing	100	μg	ml-1	ampicillin	was	incubated	with	a	colony	of	each	of	the	constructs	at	37°C	and	shacked	 at	 200	 RPM	 overnight.	 10	 ml	 of	 the	 overnight	 culture	 was	 used	 to	inoculated	 12x	 1	 L	 LB	 containing	 the	 same	 amount	 of	 ampicillin	 and	 grown	 at	37°C	 until	 OD600	 ~	 0.6.	 Cells	 were	 then	 induced	 with	 0.4	 mM	 IPTG	 and	 the	temperature	decreased	to	25°C.	The	cells	were	grown	for	16	hours	and	harvested	by	centrifugation	at	6,200	g	(JLA	8.1000	rotor,	Beckman	Coulter).	
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4.2.2.	Omp35	and	Omp36	purification		
	
	Cell	 pellets	 were	 re-suspended	 in	 lysis	 buffer	 (5-10	ml	 of	 buffer	 per	 gr	 of	 cell	paste)	(Appendix	A.3)	and	lysed	by	two	passes	through	a	chilled	cell	disruptor	at	30	 kpsi.	 Cellular	 debris	 were	 removed	 by	 centrifugation	 at	 10,000	 g	 (JA	 25.50	rotor,	 Beckman	 Coulter).	 The	 total	 membrane	 fraction	 was	 collected	 by	ultracentrifugation	 at	 100,000	 g	 (50.2	 Ti	 rotor,	 Beckman	 Coulter)	 at	 4	 °C	 for	 1	hour.	The	membranes	were	solubilized	in	50	mM	Na3PO4	pH	8,	250	mM	NaCl	and	7%	 Octyl-POE	 and	 left	 stirring	 at	 4°C	 overnight.	 Soluble	 material	 was	 then	recovered	by	ultracentrifugation	at	100,000	g,	at	4°C	for	1	hour.	The	supernatant	containing	 the	 solubilized	 protein	 was	 incubated	 with	 5ml	 of	 Ni-NTA	 resin	(Qiagen,	UK)	and	10	mM	imidazole	pH	8	at	4°C	 for	2	hours.	The	resin	was	 then	washed	with	 10	 CV	 of	washing	 buffer;	 50	mM	Na3PO4	pH	 8,	 250	mM	NaCl,	 1%	Octyl-POE	 and	 30	 mM	 imidazole	 pH	 8.	 The	 protein	 was	 eluted	 with	 the	 same	buffer	containing	250	mM	imidazole.	1	mg	of	His6-tagged	TEV	protease	was	added	to	the	eluted	protein	and	dialyzed	in	SnakeSkin	tubing	(Thermo	Scientific)	against	a	buffer	containing	10	mM	imidazole	at	4°C	overnight.	The	dialyzed	sample	was	passed	through	a	0.45	μm	syringe	filter	and	applied	to	a	5	ml	His-trap	column	(GE	Healthcare).	 The	 cleaved	 protein	 was	 collected	 from	 the	 flow-through	 fraction	and	 further	 purified	 by	 gel	 filtration	 using	 a	 16/	 60	 Superdex	 200	 pg	 (GE	Healthcare)	equilibrated	with	2	CV	of	a	buffer	containing	10	mM	Tris-HCl	pH	8,	150	mM	NaCl	and	0.45%	(w/v)	C8E4.	The	protein	was	concentrated	to	10	mg	ml-1	
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for	 crystallization.	 Purity	 and	 integrity	were	monitored	on	 SDS-PAGE	 (NuPAGE,	Invitrogen)	and	mass	spectrometry.			
4.2.3	Omp35	and	Omp36	crystallization				Different	 commercial	 screens	 were	 used	 for	 initial	 trials	 (Appendix	 B).	 The	screens	were	dispensed	into	a	96-well	sitting	drop	plate	(Intelli-Plate®,	ARI)	using	a	Gryphon	robot,	at	a	protein:reservoir	ratio	of	1:1	and	1:2.	When	required	hits	were	optimized	by	hanging-drop	vapor	diffusion	technique.	30	%	(v/v)	ethylene	glycol	 was	 used	 as	 cryoprotectant	 to	 harvest	 and	 cool	 flash	 crystals	 in	 liquid	nitrogen.	Listed	below	(Table	4.1)	are	the	crystallization	conditions	that	gave	the	crystals	used	for	data	collection.				
Table	4.1.	Omp35	and	Omp36	crystallization	conditions.	Omp35	 0.05 M Magnesium sulfate, 8% (w/v) PEG 8000	Omp36	 0.1 M Tris-HCl pH 8.5, 8% (w/v) PEG 8000		
4.2.4	Omp35	and	Omp36	data	collection	and	structure	determination	
	A	data	set	of	both	Omp35	and	Omp36	was	collected	at	the	Diamond	Synchrotron	Light	 Source	 (UK),	 beam-line	 i02,	 i04	 respectively.	 Data	 were	 processed	 using	Mosflm	 [237]	 and	 scaled	with	 SCALA.	The	 structures	were	 solved	by	molecular	replacement	 [187]	 to	 a	 resolution	 of	 2.85	 Å	 (Omp35)	 and	 2.45	 Å	 (Omp36).	OmpK36	 (ID	PDB:	 1OSM)	was	 used	 as	 search	model	 to	 solve	Omp36	 structure,	while	 OmpF	 (ID	 PDB:	 2OMF)	 was	 used	 as	 search	 model	 to	 solve	 Omp35.	 The	
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structures	 were	 built	 manually	 using	 Coot	 [188]	 and	 refined	 using	 REFMAC5	[189].	Data	quality	was	checked	by	Molprobity	[238].		
4.2.5	Liposome	swelling	assay	
	OmpC	 and	OmpF	porins	 used	 for	 the	 liposome	 swelling	 assay	were	 purified	 by	our	 collaborators	 from	 the	 Jacobs	 University	 in	 Bremen	 (Grermany).	 Liposome	swelling	 assay	 data	 on	 OmpE35/36	 and	 OmpK35/36	 were	 obtained	 by	 our	collaborators	from	Newcastle	University	(UK).			Liposome	 swelling	 assay	was	 carried	 out	 following	 the	 procedure	 described	 by	Nikaido	[239]	(Figure	4.1).	Liposome	vesicles	were	prepared	by	mixing	100	mg	of	dihexacetyl	phosphate	dissolved	in	0.5	ml	of	CHCl3	and	2	ml	of	L-α-phosphatidyl	choline	(both	Sigma).	250	μl	of	the	mixture	was	dried	under	vacuum	for	2	hours.	300	μl	 of	 distilled	water	was	 added	 to	 the	dried	 liposomes	 along	with	30	μg	of	either	 Omp35,	 Omp36,	 OmpC,	 or	 OmpF.	 The	 solution	 was	 then	 sonicated	 in	 a	Branson	bath-type	sonicator	for	one	minute.	The	resulting	mixture	was	left	drying	under	vacuum	overnight.	For	the	blank	control,	the	protein	was	substituted	with	buffer.	Dried	proteoliposomes	were	resupended	in	12	mM	stackyose	dissolved	in	10	mM	Hepes	pH	7.	The	mixture	was	left	at	room	temperature	(RT)	for	two	hours	before	 starting	 the	 experiments.	 Consecutively,	 5-10	 μl	 of	 the	 liposome	 was	quickly	 mixed	 with	 200	 μl	 of	 an	 isotonic	 solution	 containing	 the	 substrates	(nutrient	or	antibiotic)	to	be	tested.	The	concentration	of	the	substrate/antibiotic	ranged	 between	 8-20	 mM	 (see	 Table	 4.3).	 The	 correct	 concentration	 was	
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determined	by	detecting	 the	concentration	at	which	 the	blank	did	not	 show	(or	showed	 less	 that	5%)	any	variation	of	optical	density	at	400	nm.	Permeation	of	the	 tested	 antibiotics	 through	 the	 porins	 was	 assayed	 by	 determining	 the	variation	of	optical	density	at	400	nm.	Readings	were	taken	every	5	seconds	for	one	minute.	Measurements	 from	 the	 same	 set	 of	 proteoliposome	were	 taken	 in	triplicate.			
	
	
Figure	4.1:	Schematic	representation	of	liposome	swelling	assay.	Liposome	vesicles,	containing	 the	 target	porins,	 are	mixed	 in	a	 solution	containing	 the	antibiotic	 to	 test.	 If	the	antibiotic	enters	the	porins,	water	will	follow	and	cause	the	liposome	vesicles	to	swell	and	eventually	burst.	Picture	adapted	from	[240].		
	
							
An#bio#c	 						Stackyose	
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4.3	Results	
	
4.3.1	Omp35	and	Omp36	purification	
	Codon	optimized	genes	for	Omp35	and	Omp36	were	cloned	into	a	pTAMAHisTEV	vector,	which	carries	a	TamA	signal	peptide	and	an	N-terminus	hexa-histidine	tag	followed	by	a	TEV	cleavable	site.	ΔOmp8	(DE3)	E.	coli	porin-null	strain	[241]	was	used	to	overexpress	both	proteins.	Membranes	were	solubilized	directly	in	Octyl-POE	and	the	extracted	proteins	were	isolated	using	nickel	resin;	TEV	cleaved	and	further	purified	using	 size	 exclusion	 chromatography.	During	 the	 size	 exclusion	chromatography	Octyl-POE	was	exchanged	to	C8E4,	a	more	suitable	detergent	for	crystallography	experiments.	The	eluted	protein	was	then	concentrated	to	10	mg	ml-1.	The	SEC	profile	showed	a	single	peak	for	each	of	the	purified	proteins	(Figure	4.2).	 Fractions	 were	 evaluated	 by	 SDS-PAGE	 and	 identified	 by	MS.	 Omp35	 and	Omp36	purifications	yielded	1-1.5	mg	of	protein	per	liter	of	LB	media.	
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Figure	4.2:	Omp35	and	Omp36	purification.	(A)	Shows	the	SEC	profile	of	Omp35	and	the	SDS-PAGE	gel	of	the	eluted	fractions.	M	is	the	ladder,	line	1-9	are	the	eluted	fractions.	(B)	Shows	the	SEC	profile	of	Omp36	and	the	SDS-PAGE	gel	of	the	eluted	fractions.	M	is	the	ladder	and	lines	1-11	are	the	eluted	fractions.	In	lines	7	to	11	is	visible	an	extra	band,	at	75	kDa.	This	band	was	confirmed	by	mass-spectrometry	 to	be	a	 contaminant.	For	both	Omp35	and	Omp36	SEC,a	16/60	200	pg	 (GE)	 column	was	used.	The	 elution	 volume	of	both	Omp35	and	Omp36	was	compared	to	the	elution	volumes	of	molecular	weight	(MW)	markers	 (Bio-rad)	 (used	 to	 calibrate	 the	 column)	 in	 order	 to	 analyse	 their	 oligomeric	state.	Both	proteins	were	found	to	be	trimeric.		
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4.3.2	Omp35	and	Omp36	crystallization	and	structure	determination	
	Omp35	 and	 Omp36	 crystals	 appeared	 within	 a	 week.	When	 necessary	 crystals	were	optimized	by	hanging	drop	vapor	technique	(final	crystallization	conditions	for	 each	 protein	 are	 listed	 in	 4.1)	 (Figure	 4.3).	 Crystals	were	 cryo-protected	 in	ethylene	glycol	and	analyzed	by	synchrotron	radiation	at	Diamond	Light	Source,	beam	 line	 iO2,	 iO4-1	 for	Omp35	 and	Omp36,	 respectively.	Omp35	data	 set	was	processed	 to	 a	 resolution	 of	 2.85	 Å	 in	 the	 space	 group	 I222	 and	 solved	 by	molecular	 replacement	 using	 OmpF	 (PDB	 code:	 1OMF)	 as	 the	 search	 model.	Omp36	data	set	was	processed	to	a	resolution	of	2.47	Å	in	the	space	group	P3	and	solved	by	molecular	replacement	using	OmpK36	(PDB	code:)	as	the	search	model.	Analysis	of	Mathew’s	coefficient	(Mathew’s	coefficient:	2.19	and	2.32	for	Omp35	and	 Omp36,	 respectively)	 showed	 a	 trimeric	 arrangement	 in	 the	 cell	 unit.	 For	both	structures,	the	quality	of	the	structures	was	assessed	using	Molprobity.	Data	collection	and	refinement	statistics	are	shown	in	table	4.2.	
	
Figure	 4.3:	 Omp35	 and	 Omp36	 crystals.	 (A)	 Omp35	 and	 (B)	 Omp36	 crystals	 under	visible	light.		
	
300μm	300μm	A.	 B.	
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Table	4.2.	Data	collection,	refinement	and	validation	statistics.	
	 Omp35	 Omp36	Beam	line	 iO2	 iO4	Space	group	 I222	 P3	Cell	dimensions	a,b,c	(Å)	 111.57,	115.94,	216.66		 125.09,	125.09,	126.54	Cell	dimensions	α,β,γ	(°)	 90,	90,	90	 90,90,120	Resolution	(Å)	 108.56-2.85(3.0-2.85)	 56.07-2.46	(2.5-	2.46)	Rmerge	 0.11	(0.52)	 0.08	(0.2)	Completeness	(%)	 92.9	(85.5)	 99.27	(99.0)	Multiplicity	 2.5	(2.5)	 3.1	(3.1)	I/σ(I)	 6.3	(1.3)	 9.6	(3.8)	CC	1/2	
Refinement	
	
0.99	(0.68)	 0.99	(0.60)	
Rfactor/Rfree	(%)	 21.33/26.0	 19.5/23.9	N°	of	unique	reflections	 33222	 74780	N°	of	residues	 337	 335	Water	 -	 98		
Rmsd		 	 	Bonds	length	(Å)	 0.010	 0.015	Bonds	angles	(Å)	 1.47	 1.7	
	
MolProbity	
		
	 	
Ramachandran	outliers	(%)	 0.3	 0.4	Ramachandran	favored	(%)	 95.24	 93.5	Clash	score	 3.1		 5.5	Molprobity	score	 1.63		 1.73	
	
*(Values	in	parentheses	are	for	the	highest-resolution	shell)	
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	4.3.3	Crystal	structure	of	Omp35	and	Omp36			The	 crystal	 structures	 of	 Omp35	 and	 Omp36	 show	 similar	 architecture	 as	expected	 from	 their	 high	 degree	 of	 sequence	 identity	 (%)	 (Figure	 4.4).	 Each	trimer	consists	of	 three	16-β-stranded	monomers,	with	 long	external	 loops	(L1-L7)	and	short	periplasmic	 turns	 (T1-T7)	 (Figure	4.4)	As	common	 for	porins,	L3	folds	back	into	the	channel	forming	the	so-called	“eyelet”	or	constriction	zone	of	the	pore.	Pymol	measurements	 indicated	a	 larger	pore	diameter	 for	Omp35	(11	Å)	when	compared	to	Omp36	(8Å).	At	the	constriction	zone	of	both	Omp35	and	Omp36,	 highly	 conserved	 negatively	 charged	 residues	 (D100,	 E110,	 D114	 in	Omp35	 and	 Omp36)	 interact	 with	 a	 cluster	 of	 arginine	 and	 lysine	 (also	 highly	conserved)	 present	 on	 the	 barrel	 wall	 facing	 the	 loop,	 creating	 a	 transverse	electric	field	(R38,	K42,	K82,	R93,	R160	in	Omp35	and	R37,	K41,	K82,	R93,	R166	in	Omp36).	High	 levels	 of	 heterogeneity	 are	present,	 instead,	 at	 the	 level	 of	 the	external	 loops,	 especially	 in	 L4	 and	 L5.	 In	 particular,	 deletions	 in	 L4	 and	 L5	 of	Omp35	generate	 shorter	 loops	when	 compared	 to	L4	and	L5	 in	Omp36	 (Figure	4.5).		The	electrostatic	potential	of	both	structures	showed	that,	the	external	side	of	the	barrel	is	uncharged	while,	 inside	the	barrel,	at	the	level	of	the	constriction	zone,	there	 is	 a	 clear	 segregation	 of	 charges.	 Both	 negatively	 and	 positively	 charged	residues	are	present	at	 the	 level	of	 the	external	 loops	and	the	periplasmic	turns	(Figure	4.6).				
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Figure	4.4:	Sequence	alignment	of	Omp35	and	Omp36.	Conserved	negatively	charged	amino	 acids	 in	 L3	 are	 indicated	 with	 red	 triangles.	 Positively	 charged	 amino	 acids,	opposite	the	L3,	are	indicated	with	blue	arrows.	L4	and	L5	are	boxed	in	black.	
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Figure	4.5:	Crystal	structures	of	Omp35	and	Omp36.	(A)	Side	view	of	Omp35	trimer.	(B)	Extracellular	view	of	Omp35	monomer.	Loops	are	 labelled	 in	bold.	 (C)	Side	view	of	Omp35	trimer.	(D)	Extracellular	view	of	Omp35	monomer.	Loops	are	labelled	in	bold.					
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Figure	 4.6:	 Electric	 potential	 of	 Omp35	 and	 Omp36.	 Side	 view	 of	 Omp35	 (A)	 and	Omp36	 (B)	 channel.	 Extracellular	 and	 periplasmic	 view	 of	 Omp35(C)	 and	 Omp36	 (D)	monomer.									
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4.3.4	Liposome	swelling	assay		Liposome	swelling	assay	(LSA)	was	performed	in	order	to	analyse	the	permeation	of	 different	 substrates	 (glycine,	 arginine,	 glutamic	 acid	 and	 glucose)	 and	antibiotics	 (penicillins,	 carbapenems	 and	 cephalosphorins)	 (Table	 4.3)	 through	the	pore	of	Omp35	and	Omp36.	Each	measurement	was	normalised	against	 the	permeation	rate	of	the	amino	acid	glycine.	Glycine	can	easily	translocate	through	porins	 due	 to	 its	 small	 size.	 All	 molecules	 show	 higher	 permeability	 through	Omp35	compared	to	Omp36.	Among	the	antibiotics	tested,	the	zwitterionic	ones	(meropenem,	imipenem	and	cefepime)	show	higher	permeability	rate,	over	40%.	On	 the	 contrary,	 negatively	 charged	 antibiotics	 (ceftazidime,	 cefotaxime,	piperacillin	 and	 ticarcillin)	 show	 less	 than	 30%	 permeability	 rate.	 Overall,	meropenem	 showed	 the	 highest	 rate	 of	 permeation	 while	 the	 penicillin-like	antibiotics	showed	the	lowest	(Figure	4.6).												
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Table	4.3.	Charge	and	molecular	weight	of	the	antibiotics	used	for	the	LSA.		
Name	 Charge	 Molecula	 weight	
(Da)	
Concentration	
(mM)	
Glycine	 (+,-)	 75	 17	
Arginine	 (+,+,-)	 174	 17	
Glutamate	 (+,-,-)	 146	 12	
Glucose	 (0)	 180	 12	
Penicillins	 	
Ampicillin	 (+,-)	 349	 12	
Ticarcillin	 (-,-)	 382	 10	
Piperacillin	 (-)	 517	 10	
Carbapenems	 	
Ertapenem	 (+,-,-)	 475	 15	
Imipenem	 (+,-)	 299	 12	
Meropenem	 (+,-)	 383	 12	
Cephalosphorins	 	
Cefotaxime	 (-)	 454	 12	
Cefepime	 (+,-)	 481	 8	
Ceftazidime	 (+,-,-)	 546	 10					
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Figure	 4.7:	 Liposome	 swelling	 assay	 chart.	 Relative	 permeation	 rate	 of	 several	substrates	 through	 Omp35	 and	 Omp36.	 Measurements	 are	 taken	 in	 triplicate	 and	normalized	 against	 glycine	 permeation	 (=100).	 Error	 bars	 indicate	 standard	 deviation	(SD).	 Concentration	 of	 the	 substrates	 are	 listed	 in	 Table	 4.3.	 In	 general,	 zwitterionic	antibiotics	 (meropenem,	 imipenem	 and	 cefepime)	 show	 high	 rate	 of	 permeation	 (over	40%).	 On	 the	 contrary,	 negatively	 charged	 antibiotics	 (ceftazidime,	 cefotaxime,	piperacillin	and	ticarcillin)	show	lower	permeation	rate.	
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4.4	Discussion	
	
4.4.1	Overall	structures	of	E.	aerogenes	major	porins	
	In	 this	 study,	 we	 present	 the	 X-ray	 structures	 of	 the	 two	major	 porins	 from	E.	
aerogenes,	Omp35	 and	 Omp36.	 The	 structures	 we	 obtained,	 showed	 a	 trimeric	arrangement,	 as	 already	 indicated	 from	 the	 SEC	 profile.	 Overall,	 the	 structural	features	 observed	 in	 Omp35	 and	Omp36	 are	 common	 to	 all	 the	 general	 porins	characterized	 so	 far	 in	 the	Enterobacteriaceae	 family.	 A	 barrel	 consisting	 of	 16	anti-parallel	 β-strands	 linked	 together	 by	 long	 extracellular	 loops	 (L1-L7)	 and	short	periplasmic	turns	(T1-T7).	The	constriction	zone	of	the	pore	encloses	highly	conserved	residues	whereas	the	external	loops	are	different.		.	
4.4.2	Structural	comparison	of	OmpC-like	and	OmpF-like	porins	in	
Enterobacteriaceae		
	General	 porins	 from	 the	Enterobacteriaceae	 family	 (Omp35/36	 of	E.	 aerogenes,	OmpE35/E36	of	E.	cloacae,	OmpF/C	of	E.	coli	and	OmpK35/K36	of	K.	pneumonia)	share	high	sequence	identity	(>70%)	and	therefore	similar	structural	architecture	(Table	4.4).							
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Table	4.4.	Sequence	identity	and	r.m.s.d	of	OmpC-like	and	Ompf-like	proteins.		
		In	both	OmpC-like	and	OmpF-like,	a	strong	transverse	electric	 field	 is	generated	by	the	separation	of	charged	residues	on	opposite	sides	of	the	constriction	zone.	The	acidic	residues	from	the	eyelet	of	OmpF	(D113,	E117,	D121),	are	conserved	in	all	structures,	however	some	differences	are	found	at	the	level	of	the	arginine	and	lysine	 cluster.	 From	 the	 top	 of	 such	 cluster,	 R167	 is	 conserved	 in	 Omp35	 and	OmpK35	 while	 it	 is	 replaced	 in	 others	 by	 an	 uncharged	 amino	 acid:	 L167	 in	OmpC,	 OmpE35	 and	 OmpE36,	 Q167	 in	 Omp36	 and	 S167	 in	 OmpK36.	 The	positively	charged	residues	from	the	basic	ladder	inside	the	CR	are	conserved	in	all	OmpF-like	structures	but	K80	that	is	replaced	by	a	tryptophan	(W80)	in	OmpC,	and	all	OmpC-like	porins	(Omp36,	OmpE36	and	OmpK36).	
	
	
		 OmpF	 OmpE35	 OmpK35	 Omp35	 OmpC	 OmpE36	 OmpK36	 Omp36	OmpF	 				-	 0.62(317)	 1.0(312)	 1.0(313)	 0.93(324)	 0.93(322)	 1.0(324)	 1.0(288)	OmpE35	 80	 							-	 0.92(317)	 1.0(317)	 0.81(325)	 0.79(325)	 0.85(325)	 0.89(288)	OmpK35	 58	 58	 								-	 0.58(328)	 0.90(324)	 0.93(325)	 0.90(322)	 0.90(317)	Omp35	 56	 56	 95	 						-	 0.96(318)	 0.96(317)	 0.94(314)	 0.94(315)	OmpC	 64	 66	 56	 57	 					-	 0.51(340)	 0.61(339)	 0.68(334)	OmpE36	 66	 67	 58	 57	 88	 								-	 0.60(340)	 0.56(335)	OmpK36	 64	 66	 62	 62	 80	 83	 						-	 0.47(335)	Omp36	 60	 66	 61	 60	 78	 81	 91	 						-	
Percentage	of	identity	among	sequences	
R.M.S.D	(Cα	Carbons)	
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Figure	 4.8:	 Superimposition	 of	 OmpF	 and	 OmpC	 orthologs.	 OmpF-like	 porins	superimposition.	(A)	View	from	the	side	(B)	extracellular	view.	Residues	involved	in	the	formation	of	the	electric	field	are	depicted	as	sphere.	OmpC-like	porins	superimposition.	(C)	View	from	the	side	(D)	extracellular	view.	Residues	involved	in	the	formation	of	the	electric	field	are	depicted	as	sphere.		
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4.4.3	Liposome	swelling	assay	
		We	analyzed	the	permeation	of	nine	clinical	relevant	antibiotics	through	the	two	
E.	aerogenes	porins.	Zwetterionic	antibiotics	showed	a	higher	rate	of	permeation	compared	 to	 negatively	 charged	 antibiotics.	 As	 expected	 from	 is	 larger	 pore,	Omp35	has	higher	permeability	than	Omp36.			We	 also	 analyzed	 permeations	 of	 the	 above-mentioned	 antibiotics	 through	 the	OmpC-like	and	OmpF-like	porins.	Once	again	as	might	be	expected	from	the	pore	sizes	 the	 antibiotics	 have	 a	 higher	permeability	 through	OmpF	and	orthologues	Omp35,	 OmpE35,	 OmpK35	 than	 OmpC	 and	 orthologues	 Omp36,	 OmpE36,	OmpK36.	 The	 liposome	 swelling	 assay	 results	 for	 OmpF	 permeability	 are	 in	agreement	 with	 previous	 liposome	 swelling	 assay	 data	 and	 with	 influx	 rate	measurements	in	intact	cells.		The	 zwitterionic	molecules	meropenem,	 imipenem	and	 cefepime	 exhibited	high	relative	 permeability	 through	 all	 porins.	 Interestingly,	 ampicillin,	 had	 lower	relative	permeability,	resembling	more	the	negatively	charged	molecules	such	as	ceftazidime,	 cefotaxime,	 piperacillin	 and	 ticarcillin	 which	 displayed	 very	 low	permeabilities	 In	 contrast,	 ertapenem,	 which	 has	 a	 net	 negative	 charge	 shows	elevated	 permeability,	 similar	 to	 that	 of	 zwitterionic	 molecules,	 except	 via	OmpE35	and	OmpE36,	the	only	species	specific	effect	that	was	detected.	Overall,	meropenem	 showed	 the	 highest	 porin	 permeability	 while	 piperacillin	 and	ticarcillin	had	the	lowest.			
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Figure	 4.9:	 Liposome	 swelling	 assay	 of	 Enterobacteriacea	 orthologs.	 Relative	permeations	of	several	substrates	through	OmpC	and	OmpF-	like	porins.	Measurements	were	 taken	 in	 triplicate	 and	 normalized	 against	 glycine	 permeation	 (=100).	 Error	 bars	indicate	 standard	 deviations.	 Overall,	 OmpF-like	 (OmpF,	 Omp35,	 OmpE35,	 OmpK35)	porins	have	higher	permeability	than	the	OmpC-like	(OmpC,	Omp36,	OmpE36,	OmpK36)	ones.	 Among	 the	 antibiotics	 tested,	 the	 zwitterionic	 ones	 (meropenem,	 imipenem	 and	cefepime)	 show	 high	 rate	 of	 permeation	 (over	 40%)	 whereas,	 negatively	 charged	antibiotics	 (ceftazidime,	 cefotaxime,	piperacillin	and	 ticarcillin)	 show	 lower	permeation	rate.		
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General	porins	represent	 the	main	path	 through	which	polar	antibiotics	such	as	fluoroquinolones,	 penicillins,	 cephalosporins	 and	 carbapenems	 can	 enter	 the	bacterial	 cell	 [242],[243].	 Diffusion	 of	 such	 antibiotics	 does	 not	 occur	 by	 a	recognition-binding	mechanism,	but	instead	is	driven	by	an	internal	electric	field	that	guides	the	molecules	inside	the	cell	[24].	The	importance	of	such	electric	field	in	the	constriction	zone	has	been	highlighted	in	multidrug-resistant	E.	coli	clinical	strains	[233].	All	atoms	in	silico	modeling	analysis,	obtained	in	collaboration	with	Prof.	Ceccarelli’s	team,	predicted	that	molecules	with	a	negative	net	charge	would	have	a	lower	permeability	than	molecules	with	a	net	positive	charge.	In	fact,	the	positive	 charge	would	 compensate	 the	 energy	 barrier	 found	 at	 the	 level	 of	 the	constriction	zone.	This	is	in	agreement	with	the	cation-selectivity	of	all	OmpF-like	and	 OmpC-like	 porins,	 and	with	 the	 data	 obtained	 on	 accumulation	 of	 positive	molecules	 in	 bacteria	 [244].	 However,	 our	 data	 showed	 that	 the	 negatively	charged	 antibiotic	 ertapenem	 exhibits	 high	 permeability	 through	 all	 the	 porins	tested.	Those	data	brought	us	to	the	conclusion	that	it	is	not	necessary	to	have	a	total	positive	charge	to	improve	the	rate	of	permeation	but	instead	it	is	the	ability	of	 the	 molecule	 to	 align	 its	 dipole	 moment	 inside	 the	 constriction	 zone.	 In	particular	when	the	dipole	of	the	molecule	is	perpendicular	to	both	the	long	axis	of	the	molecule	itself	and	to	the	transversal	electric	field	of	the	pore,	permeability	is	enhanced.	In	other	words	the	distribution	of	charges	in	the	molecule	is	crucial	for	an	increased	rate	of	permeation.			
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Figure	 4.10:	 Antibiotics	 molecular	 structures	 and	 dipole	 moment.	 Meropenem,	ertapenem,	ampicillin	and	 ticarcillin	molecular	structures.	Structures	were	downloaded	from	 PubChem.	 The	 dipole	 moment	 was	 calculated	 and	 kindly	 provided	 by	 Dr.	 Silvia	Acosta-Gutierrez.																									
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4.4	Conclusions	
	In	 this	 study	 we	 presented	 the	 X-ray	 structures	 of	 the	 two	 major	 porins	 in	 E.	
aerogenes,	Omp35	and	Omp36.	Sequence	and	structural	alignment	of	Omp35/36	with	their	orthologs	in	E.	cloacae	(OmpE35/36)	K.	pneumonia	(OmpK35/36)	and	
E.	 coli	 (OmpC	 and	 OmpF)	 displayed	 high	 level	 of	 homology.	 However	 slight	difference	were	found	at	the	level	of	the	basic	ladder,	especially	for	the	OmpC-like	family.		We	 also	 analyzed	 the	 permeation	 of	 nine	 antibiotics,	 currently	 used	 in	 gram-negative	 bacteria	 infections,	 through	 three	 sets	 of	 orthologs,	 all	 showing	 subtle	differences.	We	observed	difference	in	the	rate	of	permeation	among	the	different	antibiotics,	 with	 the	 zwitterionic	 antibiotics	 being	 the	most	 permeable	 and	 the	negatively	 charged	 one	 the	 less	 permeable.	 In	 particular	 we	 noticed	 that	 the	ability	of	a	molecules	to	align	its	dipole	to	the	electric	field	at	the	constriction	zone	correlated	with	increased	permeation.	These	results	should	be	taken	into	account	in	the	design	of	new	drugs.								
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5.	General	conclusions	and	outlooks	
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In	this	work,	we	have	presented	the	structural	and	functional	analysis	performed	on	MOMP	 and	Omp50	 from	C.	 jejuni	 and	Omp35	 and	Omp36	 from	E.	aerogenes.	Both	bacteria	are	pathogenic	for	humans,	causing	gastrointestinal	and	respiratory	infections,	respectively.		MOMP	was	expressed	in	the	native	C.	jejuni	and	its	x-ray	structure	was	solved.	The	structure	showed	that	MOMP	was	a	trimeric	porin	of	18	β-strand	monomers.	The	obtained	structure	was	compared	to	the	structure	of	the	recombinantly	expressed	MOMP,	and	despite	differences	in	the	LPS	composition	between	E.	coli	and	C.	jejuni,	we	found	the	two	structures	to	be	identical.	We	then	focused	our	attention	on	the	calcium	binding	site	 found	at	 the	constriction	zone.	Electrophysiology	analysis	of	MOMP	behavior	in	the	presence	and	absence	of	calcium	led	us	to	conclude	that	the	metal	 ion	 is	 important	 for	 the	 stability	 of	 the	 structure,	 as	 it	 holds	 together	 a	number	of	key	loops	(L3,	L4	and	L6)	involved	in	its	binding.	Furthermore,	in	silico	data	obtained	in	collaboration	with	the	University	of	Cagliari	gave	us	some	insight	on	 the	 functional	 role	 of	 the	 calcium,	 specifically,	 highlighting	 the	 effect	 of	 the	calcium	on	the	ciprofloxacin	permeation.				It	 is	well	 established	 that	 the	 constriction	 zone	 of	 porins	 plays	 a	 crucial	 role	 in	substrates	permeation	and	thus	any	alterations	at	 this	 level	can	 lead	to	 impaired	diffusions	 [243].	 In	MOMP,	 the	 presence	 of	 the	 calcium	 neutralizes	 the	 negative	charges	of	the	residues	D155,	D120	and	E288	in	the	eyelet,	weakening	the	electric	field	 and	 increasing	 the	 energy	 barrier	 for	 translocation.	 Following	 these	
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observations,	 it	 would	 be	 useful	 to	 test	 several	 antibiotics,	 using	 for	 example	liposome	 swelling	 assay,	 and	 to	 analyze	 their	 permeation	 rate	with	 and	without	calcium.	 This	 would	 provide	 us	 with	 more	 data	 on	 how	 the	 calcium	 effects	 the	translocation	of	different	classes	of	antibiotics	and	thus	improve	the	design	of	new	ones.			Omp50,	also	a	porin	from	C.	jejuni,	was	also	the	object	of	study	in	this	work.		Omp50	purification	was	first	attempted	in	the	native	Campylobacter,	but	due	to	the	low	 expression	 level	 and	 low	 purity	 we	 decided	 to	 use	 a	 recombinant	 system.	Omp50	was	successfully	expressed	 in	E.	coli	 and	 the	purified	porin	showed	pore	activity,	 when	 inserted	 in	 a	 lipid	 bilayer	 comparable	 to	 the	 protein	 natively	expressed.	 Crystallization	 of	 Omp50	was,	 however,	 hard	 to	 achieve.	 Omp50	was	also	tested	 in	order	to	 find	evidences	of	 its	proposed	kinase	activity.	None	of	 the	experiments	 we	 performed,	 with	 either	 the	 recombinant	 or	 the	 native	 protein,	suggested	 that	Omp50	 is	able	 to	auto-phosphorylize	or	 is	able	 to	hydrolyze	ATP.	Hence,	 our	 data	 are	 in	 disagreement	with	 that	 proposed	 by	 Corcionivoschi	 et	al	[207].						
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Lastly,	 we	 determined	 the	 X-ray	 structures	 of	 Omp35	 and	 Omp36	 from	 E.	
aerogenes,	orthologues	of	the	E.	coli	OmpF	and	OmpC,	respectively.	The	structures	we	 obtained	 showed	 that	 both	 Omp35	 and	 Omp36	 were	 homotrimer	 of	 16	 β-strands	 monomers.	 Omp35	 and	 Omp36	 structures	 also	 showed	 high	 levels	 of	homology	 with	 OmpC	 and	 OmpF	 from	 E.	 coli,	 OmpE35/36	 from	 E.	 cloacae	 and	Ompk35/36	from	K.	pneumonie.		
We	analyzed	 the	permeation	of	 clinically	 relevant	antibiotics	 through	 the	OmpC-like	 (OmpC,	 Omp36,	 OmpE36,	 OmpK36)	 and	 the	 OmpF-like	 (OmpF,	 Omp35,	OmpE35,	OmpK36)	porins	using	liposome	swelling	assay.	We	detected	difference	in	the	rate	of	permeation	among	the	different	antibiotics.	Specifically,	 in	both	the	OmpC-like	 and	 OmpF-like	 porins,	 we	 observed	 that	 the	 zwitterionic	 antibiotics	were	 the	 most	 permeable	 and	 the	 negatively	 charged	 one	 the	 least	 permeable.	Interestingly,	 the	 antibiotic	 Ertapenem,	 despite	 having	 a	 net	 negative	 charge,	showed	a	rate	of	permeation	over	80%.	Further	analysis,	(in	collaboration	with	the	University	of	Cagliari),	led	us	to	conclude	that	it	is	not	crucial	to	have	a	net	positive	charge	 to	 improve	 the	 rate	 of	 permeation	 but	 it	 is	 the	 ability	 of	 the	molecule	 to	align	 its	 dipole	 moment	 to	 the	 electric	 field	 at	 the	 constriction	 zone,	 instead,	correlated	with	increased	permeation.		
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E.	 aerogenes	 strains	 isolated	 from	 hospitalized	 patients	 have	 been	 shown	 to	 be	resistant	 to	 a	 wide	 range	 of	 antibiotics	 [220].	 Omp35	 and	 Omp36,	 E.	 aerogenes	major	 porins,	 play	 an	 important	 role	 in	 the	 multi-drug	 resistance	 phenomenon	[235].	Variation	in	their	expression	of	these	two	porins	and	mutation	at	the	level	of	the	constriction	zone	are	the	main	mechanisms	that	lead	to	antibiotic	resistance	in	
E.	aerogenes	 [235],	 [236].	The	structural	and	 functional	analysis	we	presented	 in	this	work	 represent,	 a	 good	 starting	 point	 to	 better	 understand	 translocation	 of	antibiotics	through	porins	of	pathogenic	bacteria.	In	order	to	investigate	how	(and	to	 what	 extent)	 these	 mutations	 impair	 the	 permeation	 of	 different	 classes	 of	antibiotics	when	compared	to	the	wild-type,	such	analysis	could	also	be	extended	to	 Omp35	 and	 Omp36	 (and	 also	 their	 orthologues)	 that	 carry	 mutations	 at	 the	level	of	the	constriction	zone.	
	
Antibiotics	 resistance	 in	 Gram-negative	 bacteria	 has	 become	 a	 threat	 for	 public	health	worldwide.	As	 already	discussed	 in	 the	general	 introduction	of	 this	work,	porins	 play	 an	 important	 role	 in	 the	 translocation	 of	 antibiotics	 and	 thus	 in	bacteria	 resistance.	 It	 is	 for	 this	 reason	 that	 we	 structurally	 and	 functionally	characterized	 the	 major	 porins	 of	 two	 pathogenic	 bacteria.	 We	 believe	 that	 the	data	collected	in	this	study	will	give	a	better	understanding	of	drug	translocation	through	 porins	 and	 hence	 improve	 the	 rational	 design	 of	 high	 permeable	antibiotics.	
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7.	Appendices	
	
A.	Buffer	and	media	composition	
	
A.1	MOMP	
	2YT	media		 16	g	bacto	tryptone,	10	g	bacto	yeast	extract,	5				g	NaCl	(adjust	pH	to	7).	Columbia	blood	agar	 Peptone	2	g,	corn	starch	1	g,	NaCl	5g,	agar	7.3g,			5%	(v/v)	blood	sheep	Lysis	buffer	 	 	 	 10mM	Tris-EDTA	pH	7.4	Extraction	buffer	1	 20	 mM	 Tris-HCl	 pH	 7.4,	 0.1	 %	 (w/v)	 sodium	lauryl	Sarcosinate	Extraction	buffer	2	 	 	 20	mM	Sodium	sulphate	pH	7.5,	1%	(v/v)	OPOE	Anion	exchange	buffers	Buffer	A	 30	 mM	 Sodium	 sulphate,	 10	 mM	 NaCl,	 0.6	 %	(v/v)	OPOE	Buffer	B	 	 	 	 30	mM	Sodium	sulphate,	1	M	NaCl,	0.6	%	(v/v)	OPOE	SEC	buffer		 10	 mM	 Tris-HCl	 pH	 8,	 150	 mM	 NaCl,	 0.45	 %	(v/v)	C8E4	
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A.2	Omp50	
	Auto	–Induction	medium	(1L)	 ZY	 (10	 g	 N-Z-amine,	 5	 g	 yeast	 extract)	 media	supplemented	with	1mM	MgSO4,	0.5%	glycerol,	0.05%	glucose,	0.2%	lactose,	25	mM	(NH4)2SO4,	50	mM	KH2PO4,	50mM	Na2HPO4	LB	(1L)	 10	g	tryptone,	5	g	yeast	extract,	10	g	NaCl	TB	(1L)	 12	g	tryptone,	24	g	yeast	extract,	4	mL	glycerol	TPB	(1L)	 20	 g	 tryptose,	 2	 g	 dextrose,	 5	 g	 NaCl,	 2.5	 g	Na2PO4		Lysis	buffer	 50	 mM	 Sodium	 phosphate	 pH	 7.4,	 250	 mM	NaCl,	10	%	glycerol		Extraction	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	mM	β-mercaptoethanol,	7%	OPOE	Wash	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 50	 mM	 imidazole,	1%	OPOE	Elution	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 250	 mM	 imidazole,	1%	OPOE	Dialysis	buffer	 10	mM	Tris-HCl	pH	8,	 250	mM	NaCl,	 2	mM	β-mercaptoethanol,	10%	glycerol,	1%	OPOE	
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SEC	buffer	 10	 mM	 Tris-HCl	 pH	 8,	 150	 mM	 NaCl,	 0.45	 %	(v/v)	C8E4	IB	buffer	 20	mM	Hepes	pH7,	300	mM	NaCl	Refolding	buffer	 50	mM	sodium	phosphate,	 250	NaCl,	 2	mM	β-mercaptoethanol	 (supplemented	 with	 chosen	detergents)	Proteolytic	enzymes	buffers		Α-Chymotrypsin	 1	mM	HCl,	2	mM	CaCl2	Trypsine	 1	mM	HCl,	2	mM	CaCl2	Papain	 H2O	Subtilisin	A	 10	mM	NaOAc	Western	blot	buffers		Anode	buffer	1	 300	mM	Trizma	base,	20%	methanol	Anode	buffer	2	 25	mM	Trizma	base,	20%	methanol	Cathode	buffer	 5.2	 g	 amino	 capronic	 acid,	 20%	 methanol,	0.01%	SDS	
A3.	Omp35/36	LB	(1L)	 10	g	tryptone,	5	g	yeast	extract,	10g	NaCl	Lysis	buffer	 50	 mM	 Sodium	 phosphate	 pH	 7.4,	 250	 mM	NaCl,	10	%	glycerol		Extraction	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	mM	β-mercaptoethanol,	7%	OPOE	
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Wash	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 50	 mM	 imidazole,	1%	OPOE	Elution	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 250	 mM	 imidazole,	1%	OPOE	Dialysis	buffer	 10	mM	Tris-HCl	pH	8,	 250	mM	NaCl,	 2	mM	β-mercaptoethanol,	10%	glycerol,	1%	OPOE	SEC	buffer	 10	 mM	 Tris-HCl	 pH	 8,	 150	 mM	 NaCl,	 0.45	 %	(v/v)	C8E4															
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B.	Crystallization	screenings	
		PEGsI&II,	MemGold	 I&II	 crystallization	 screenings	were	 purchased	 from	Qiagen	and	Molecular	Dimension,	respectively.	Composition	can	be	found	her:	https://www.qiagen.com/products/protein/crystallization/compositiontables/	http://www.sfr-biosciences.fr/medias/documents/copy_of_document-l3/mad-es-doc-021-130716pegs-ii-suite	https://www.moleculardimensions.com/applications/upload/MD1-39%20MemGold.pdf	https://www.moleculardimensions.com/products/4234-MemGold2/		
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C.	PDB	codes	
	 Protein	name	 PDB	code	OmpC	 2j1n	LamB	 1MAL	OccD1	 4FOZ	CymA	 4D5B	OmpG	 2F1C	FhuA	 2GRX	SusCD	 2FQ6	OmpT	 1I78	OMPLA	 1QD6	BamA	 4K3B	BamB	 4XGA	MOMP	 5LDT(native),	5LDV(rec)	Omp35	 5O78	(to	be	published)	Omp36	 5O9C	(to	be	published)								
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D.	Publication	s	
